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Abstract     
Protein tyrosine phosphatase-like myo-inositol phosphatases (PTPLPs) follow an 
ordered, sequential dephosphorylation pathway that utilizes the abundant  myo-inositol-
1,2,3,4,5,6-hexakisphosphate  (InsP6)  to  produce  less-phosphorylated  myo-inositol 
phosphates  (IPs)  containing  between  one  and five  phosphoryl  groups.  To understand 
PTPLP substrate  specificity,  I  present  multiple  complex structures  of  Phytase A from 
Selenomonas  ruminantium  (PhyAsr)  and  Mitsuokella  multacida (PhyAmm;  a  tandem 
repeat) with various IPs. From these structures I demonstrated that binding of IPs by 
these enzymes is consistent with a 'lock-and-key' binding mechanism, determined binding 
differences between InsP6 and less-phosphorylated IPs, and revised the existing PTPLP 
substrate  specificity model.  As part  of this  work,  I  have produced the first  PhyAmm 
complex  structures  and  demonstrated  that  the  PhyAmm  C-terminal  repeat  binds 
substrates using identical phosphoryl binding sites as PhyAsr. Further, I have provided 
evidence that differential substrate binding in the PhyAmm N- and C-terminal repeats is 
due to electrostatic differences and a loop insertion causing steric clashes.
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Chapter 1: Literature Review
1.1 Myo-inositol phosphates
Myo-inositol  is  one  of  the  isomeric  forms  of  cyclohexanehexol,  which,  in  its 
lowest energy conformation, has five hydroxyls in the equatorial position and one in the 
axial  position  (Michell,  2008).  When  myo-inositols  contain  one  to  eight  phosphoryl 
groups they become biologically active myo-inositol phosphates (IPs) (Irvine and Schell, 
2001). IPs are ubiquitous in nature and have diverse functions, the first of which was 
discovered in 1983 (Streb et al., 1983; Michell, 2008). Roles of IPs in eukaryotic cells 
have  been  extensively  studied  since  their  identification  as  important secondary 
messengers (Streb  et  al.,  1983).  IPs  are  both  produced  and  used  by  eukaryotes  that 
synthesize specific IPs from myo-inositol, whereas few prokaryotes have methods of IP 
production; prokaryotes typically harvest IPs from the environment (Michell, 2008). Few 
roles for IPs in prokaryotes have been characterized other than functioning as a phosphate 
source and their role in pathnogensis (Norris et al., 1998; Chatterjee et al., 2003; Michell, 
2008). 
1.1.1 Myo-inositol-1,2,3,4,5,6-hexakisphosphate
The most abundant IP is myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6) which 
is commonly referred to as phytic acid or phytate when in complex with cations (Raboy, 
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2003). The  myo-isomers of inositol have the C2-phosphoryl group (P2) in the opposite 
configuration in comparison with the other five phosphoryl groups  (Figure 1.1) (Irvine 
and Schell, 2001). InsP6 is ubiquitous in eukaryotic species and was first identified as a 
phosphate and cation storage source in seeds  (Raboy, 2003). More recently, InsP6 has 
been identified as having multiple important roles in cellular processes including DNA 
repair, RNA processing, mRNA export, plant development, apoptosis, and pathogenicity 
(York et al., 1999; Hanakahi et al., 2000; Chatterjee et al., 2003; Macbeth et al., 2005; 
Tan et al., 2007; Lupardus et al., 2008; Majerus et al., 2008). The importance of InsP6 in 
cells  is  emphasized  by  the  observation  that  deletion  of  enzymes  involved  in  InsP6 
biosynthesis has a lethal phenotype in mouse embryos (Frederick et al., 2005; Verbsky et 
al., 2005). 
Figure 1.1:  Stick diagram of 1D-myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6) in 
the  energetically  favoured  chair  conformation  with  five  equatorial  and  one  axial 
phosphoryl group.
1.1.2 Eukaryotic IPs
In general, highly-phosphorylated IPs (InsP6 and InsP5) serve as cofactors while 
less-phosphorylated  IPs  are  utilized  as  second  messengers  in  signal  transduction 
pathways. The best characterized IP pathway is the Ca2+ mobilization pathway with the 
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release  factor  Ins(1,4,5)P3.  In  this  Ca2+ mobilizing  pathway,  phosphatidylinositol-4,5-
bisphosphate  (PtIns(4,5)P2)  is  hydrolyzed  to  generate  the  secondary  messenger 
Ins(1,4,5)P3 in response to several hormonal stimuli, as reviewed in Wilson et al. (2013). 
Ins(1,4,5)P3 stimulates the release of Ca2+ from the endoplasmic reticulum resulting in 
further  cellular  responses.  The  signalling  molecule  Ins(1,3,4,5)P4 is  characterized  as 
cooperative  with  Ins(1,4,5)P3 increasing  the  sensitivity  and,  in  turn,  a  longer-lasting 
signal (Gawler et al., 1990; Irvine and Schell, 2001). Additional less-phosphorylated IPs 
characterized have implications in many important biological processes and lack the C2-
phosphoryl group (P2) (Irvine and Schell, 2001; Wilson et al., 2013).
Recently,  IPs  containing  pyrophosphate  groups  (InsP7 and  InsP8)  have  been 
discovered,  as  reviewed  in  Wilson  et  al.  (2013). There  are  multiple  pyrophosphate-
containing IPs (PP-IPs) identified and one of the best characterized is diphosphoinositol 
pentakisphosphate (InsP7,  PP-InsP5),  which has the diphosphate on C5  (Wilson et  al., 
2013). PP-IPs are found in all eukaryotic cells and have high-energy phosphate bonds 
with energies similar to  adenosine triphosphate (ATP)  (Stephens et  al.,  1993).  PP-IPs 
have been characterized as energy sensors, are able to phosphorylate specific proteins in 
an  ATP  and  enzyme  independent  manner,  and  participate  in  processes  such  as 
endocytosis, exocytosis, regulation of telomere length and cell death (Saiardi et al., 2002; 
Saiardi et al., 2004; Saiardi et al., 2005; Bennett et al., 2006; Illies et al., 2007; Wilson et 
al., 2013).
1.2 Phytases
The  prokaryotic  enzymes  responsible  for  the  dephosphorylation  of  InsP6 to 
inorganic  phosphate  and  less-phosphorylated  IPs  are  collectively  known  as  phytases 
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based on their ability to hydrolyze InsP6 (Mullaney and Ullah, 2003). However, simple 
kinetic assays have demonstrated that many phytases have greater activity towards less-
phosphorylated IPs, therefore a more accurate nomenclature is myo-inositol phosphatases 
(IPases)  (Konietzny  and  Greiner,  2002;  Mullaney  and  Ullah,  2003).  Four  classes  of 
IPases have been described based on primary sequence and structural similarities. These 
four enzyme classes are β-propeller phytases (BPPs), histidine acid phosphatases (HAPs), 
purple  acid  phosphatases  (PAPs),  and  protein  tyrosine  phosphatase-like  myo-inositol 
phosphatases  (PTPLPs)  (Figure  1.2).  Enzymes  from  each  of  these  classes  remove 
multiple phosphates from InsP6 by diverse mechanisms.
IPases can be broadly divided into two major classes based on their pH optima as 
acid or alkaline, and further divided by their structure and catalytic mechanism (Mullaney 
and Ullah,  2003).  HAPs, PAPs and PTPLPs are acidic IPases and BPPs are the only 
known class of alkaline IPases (Kerovuo et al., 1998; Tye et al., 2002; Yao et al., 2012). 
1.2.1 β-propeller phytases
The BPP class of IPases adopt a β-propeller fold with an electronegative, solvent-
accessible central channel that binds five Ca2+ ions (Kerovuo et al., 1998; Kerovuo et al., 
2000; Shin et  al.,  2001; Zeng et  al.,  2011).  BPPs are dependent on the Ca2+ ions for 
substrate  binding  and  catalytic  activity  by  providing  a  favourable  electrostatic 
environment  and  have  optimal  InsP6 activity  in  the  pH range  of  7  to  8  due  to  the 
protonation state of the calcium-binding residues (Kerovuo et al., 2000; Oh et al., 2001; 
Shin  et  al.,  2001;  Oh  et  al.,  2006).  Recently,  the  complex  structure  of  a  BPP from 
Bacillus subtilis with the InsP6 substrate analogue myo-inositol-1,2,3,4,5,6-hexakissulfate 
(MIHS) was solved (Zeng et al., 2011). The complex shows no conformational changes 
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Figure 1.2:  Structures of representative IPases from the four classes. (a) Structure of a 
BPP from Bacillus subtilis in complex with Ca2+ and phosphate (sticks) (PDB: 1H6L). (b) 
Structure  of  a  HAP from  Escherichia  coli  in  complex with  InsP6 (PDB:  1DKP).  (c) 
Structure of  a  PAP dimer from  Phaseolus  vulgaris (PDB:  1KBP).  (d) Structure of  a 
PTPLP from Selenomonas ruminantium (PDB: 2PSZ). The metal ions are show as grey 
spheres, the β-sheets are blue, α-helices are red and loops are in grey.
other  than  subtle  side-chain  shifts  of  the  residues  interacting  with  the  substrate.  The 
substrate  binding  site  has  two  phosphoryl  group  binding  sites:  one  for  the  scissile 
phosphate  (cleavage  site)  and  the  other  to  bind  an  adjacent  phosphoryl  group  that 
strengthens substrate binding (Zeng et al., 2011). Only substrates that simultaneously fill 
both binding sites are hydrolyzed, which explains why these enzymes can only remove 
three phosphates from InsP6 (Figure 1.3) (Greiner et al., 2007).
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Figure 1.3:  Dephosphorylation pathway of InsP6 by a BPP (PhyC) from B. subtilis. 
1.2.2 Histidine acid phosphatases
The HAP class of IPases have the active-site phosphate binding motif RHGXRXP 
with the optimal pH at 2.5 and/or 4.5 to 6, and are not dependent on Ca2+ ions (Van Etten 
et al., 1991; Konietzny and Greiner, 2002; Mullaney and Ullah, 2003; Oh et al., 2004; 
Yao  et  al.,  2012).  They  contain  the  catalytically  active  HD  sequence  motif,  which 
facilitates substrate binding and release (Van Etten et al., 1991). HAPs utilize a two-step 
catalytic mechanism: the first step is the formation of the phospho-histidine intermediate 
with the histidine of the RHGXRXP signature sequence, which is followed by the second 
step, where the aspartic acid of the HD motif acts as a general base to abstract a proton 
from a water molecule that hydrolyzes the covalent intermediate (Liu et al., 2004; Xiang 
et al., 2004). Binding of InsP6 deep in a cleft with a positive electrostatic surface potential 
results in a conformational change (Lim et al., 2000). An active-site loop clamps down on 
the  substrate  to  stabilize  the  enzyme-substrate  complex  and  positions  the  scissile 
phosphate  for  nucleophilic  attack.  After  hydrolysis  the  product  is  released  by 
conformational changes in several active-site residues (Liu et al., 2004). The HAPs fold 
consists  of  a  conserved  α/β  catalytic  domain  and  a  variable  α  domain  that  confers 
substrate specificity (Kostrewa et al., 1999). It has also been demonstrated that the HAPs 
substrate specificity is attuned to the electrostatic properties of the active site (Kostrewa 
et  al.,  1999;  Wyss  et  al.,  1999).  Active  sites  with  great  positive  electrostatic  surface 
potential  have  relatively  narrow  substrate  specificities  for  phosphate  containing 
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compounds, while less positive active sites are associated with broad substrate specificity. 
Figure 1.4 shows a representative dephosphorylation sequence of InsP6 by an E. coli HAP 
(Greiner et al., 1993).
Figure 1.4:  Dephosphorylation pathway of InsP6 by a HAP from E. coli. InsP5 is a short-
lived intermediate with InsP4 accumulating which is  slowly hydrolyzed to InsP3 later. 
Major (85 %) and minor pathways indicated by bolded and smaller arrows, respectively.
1.2.3 Purple acid phosphatases
The PAP class of IPases consists of homodimers with each monomer composed of 
an N-terminal antiparallel β sandwich and a larger C-terminal α+β domain (Klabunde et 
al., 1996). Each monomer contributes two α-helices to the dimer interface. The optimal 
pH range for PAPs is between 4.5 and 6 (Hegeman and Grabau, 2001). PAPs have five 
conserved motifs (DXG, GDXXY, GNH(D/E), VXXH, and GHXH) that are involved in 
coordinating the binuclear Fe(III)-M(II) centre, where M can be Fe, Mn or Zn (Klabunde 
et  al.,  1996; Hegeman and Grabau, 2001; Li et  al.,  2002; Mullaney and Ullah,  2003; 
Schenk et al., 2013). The catalytic mechanism involves the direct attack of the scissile 
phosphate by an activated water coordinated by the metal centre (Klabunde et al., 1996). 
Soybean (Glycine max) PAP is the only member of the class that has been shown to have 
significant levels of InsP6 activity  (Hegeman and Grabau, 2001). At present there is no 
published data regarding the dephosphorylation pathway of these enzymes.
1.2.4 Protein tyrosine phosphatase-like myo-inositol phosphatases
PTPLPs have optimal pHs near 5 and are not dependent on metal ions (Yanke et 
al., 1999; Chu et al., 2004; Gruninger et al., 2009; Puhl et al., 2009; Yao et al., 2012). 
7
PTPLPs have the characteristic CXXGXGR(S/T) phosphate binding loop (P-loop) active-
site sequence and follow the PTP catalytic mechanism (Puhl et al., 2007). They have a 
catalytic PTP domain (α-β-α sandwich) and an additional phytase-specific domain (Phy 
domain)  implicated in their  substrate  specificity  (Chu et  al.,  2004;  Puhl  et  al.,  2007; 
Gruninger  et  al.,  2009).  PTPLPs  catalyze  the  hydrolysis  of  phosphodiester  bonds 
following a 2-step PTP-like mechanism  (Guan and Dixon, 1991; Zhang, 2003). In the 
first  step, the invariant P-loop cysteine nucleophilically attacks the scissile phosphate, 
while the invariant aspartic acid in the HD motif (GA-loop) functions as the general acid 
which protonates the IP leaving group and generates a phospho-enzyme intermediate. In 
the second step, the general acid (aspartic acid) from step one serves as the general base 
and abstracts a proton from a water molecule which then hydrolyzes the phospho-enzyme 
intermediate. 
PTPLPs, like HAPs, can be categorized as either having high activity and high 
specificity for InsP6 and other IPs or low activity towards InsP6 and broad specificity 
including other non-IP phosphate-containing compounds (Puhl et al., 2007; Puhl et al., 
2008a,b; Puhl et al.,  2009).  Phytase A from  Selenomonas ruminantium (PhyAsr) is a 
PTPLP with high activity  and specificity  for  InsP6 (Puhl et  al.,  2007).  The tandemly 
repeated Phytase A from Mitsuokella multacida (PhyAmm) has an N-terminal repeat that 
has low activity and broad specificity, while the C-terminal repeat has high activity and 
specificity for InsP6 (Gruninger et al., 2009). X-ray crystallographic structures of PhyAsr 
and PhyAmm have been solved and their pathways are shown in Figure 1.5 (Chu et al., 
2004; Puhl et al., 2007; Gruninger et al., 2009; Gruninger et al., 2012). Low activity and 
broad specificity PTPLPs have patterns of insertions and deletions similar to those of 
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PhyAmm's N-terminal  repeat,  suggesting that  these structural  elements  are  conferring 
their specificity (Gruninger et al., 2009). 
(a)
(b)
Figure 1.5:  Dephosphorylation pathways of InsP6 by the PTPLPs (PhyA) from (a) S.  
ruminantium  and  (b) M. multacida.  Major  (80  %)  and minor  pathways  indicated  by 
bolded and smaller arrows, respectively. 
1.2.4.1 Substrate binding
The structural basis of IP binding to a representative high activity and specificity 
PTPLP has  been investigated by X-ray crystallographic  methods using InsP6 and  the 
inactive PhyAsr C252S mutant (Gruninger et al., 2012). InsP6 binds deep in the cleft that 
has positive electrostatic surface potential where it makes extensive contacts with the P-
loop and Phy domain (Figure 1.6). The main-chain interactions with InsP6 are exclusively 
with  the  P-loop  while  the  rest  of  the  active-site  residues  contribute  side-chain 
interactions. In this structure, PhyAsr has P3 in the scissile phosphate location, which is 
in agreement with the pathway (Figure 1.5a) (Puhl et al., 2007; Gruninger et al., 2012).
From the PhyAsr C252S:InsP6 complex structure, a simple substrate specificity 
model can be proposed that rationalizes the known dephosphorylation pathway of PhyAsr 
based on the composition of each phosphoryl binding site (Figure 1.7, Table 1.1). The Pa 
site forms multiple direct contacts suggesting a strong interaction with InsP6, the Pb site 
has multiple solvent-mediated contacts, while the Pb' and Pc sites have few contacts which 
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are typically mediated by solvent suggesting weaker interactions. This suggests that the 
Pa and  to  a  lesser  extent  the  Pb sites  are  responsible  for  the  bulk  of  the  favourable 
interactions with the IP phosphoryl groups. In addition, the Pa' site forms multiple direct 
contacts  suggesting  strong interactions,  but  can  only  accommodate  the  axial  P2  or  a 
hydroxyl group. As a result, the substrate specificity can be explained by two simple rules 
derived from a careful analysis of the PhyAsr C252S:InsP6 complex structure: the first is 
that Pa' only accepts an axial phosphoryl group (P2) or a hydroxyl group, and the second 
is  to  preferentially  fill  the  'strong  interacting'  sites  (Pa and  Pb).  These  two  rules  are 
supported by the characterized PhyAsr and PhyAmm major dephosphorylation pathways 
(Figure 1.8) (Puhl et al., 2007).
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57 153 189 223
M. A L K I D N H D W G N K K N V I L Q D H F R P
M. I W R L D L R D W G N K D K M P A T D H I W P
S. rum V W R L D E R D W A N K H K L P A T D H V W P
D. mag V L T L D P D N Q G N A R R G G V S D H T R P
W. cho L L I L N E H N W G D - - - - S I T D H R R P
S. tes E W K V D P N N Y V N W G A D H D T N H F R P
S. aur Y A Q L V Q T N W G G V K R G T V T D H T R P
P. syr E P V F I G N N W A N A K H G L V T D H M G P
P. aca F L L V N T R G W S N A Y K Q K V T D H C R P
M. els F W R V D R H D W G N K G D L P N T D H L W P
L. pne C I V Q D V Y N W I N Q Y V A K I S D H R A P
D. inv I W R L D A R D W G N E G K K S A T D H I W P
C. tet N L V L D E K N N A N I T F Y N V T D T K L P
C. pro I V D A P G L N Y G N S K D L G I T D H H R P
A. fer V W R L D D N N W A N K N K Q P S T D H I W P
252 258 305 309 312
M. H Y H C Y A G M G R T T Y G R K A Y I E R Y Q F
M. H F H C Q A G A G R T T W K A D Y Y H Q K A H M
S. rum H F H C E A G V G R T T W K T K Y Y R E K I V M
D. mag H F H C R G G A G R T T - R D A L A R Q R L E F
W. cho H F H C S A G K G R T T W K K S H I K K R A D F
S. tes F M H C Y A G E G R T T Y K M K A S I E R R I F
S. aur H F H C R G G K G R T S - K A P F I Q E R T Q F
P. syr H I H C G V G Q G R T G - R A N L R N D R L E F
P. aca H F H C S A G Q G R T T W K H E H A E Q R A E F
M. els H F H C E A G A G R T T W K G P Y Y H E K H E M
L. pne H V H C R G G K G R T T - - T P Y Y E Q R L Q F
D. inv H F H C R A G K G R T T W K A A Y Y H E K A A M
C. tet H F H C K Q G I G R T S - - - - - - N K R I A F
C. pro H L H C K G G K G R T T Y K Q K P A K D R I E F
A. fer H F H C Q A G K G R T T W R Q T I D D N K V Y R
mul (N)
mul (C)
mul (N)
mul (C)
Figure 1.6:  ClustalW sequence alignment of PTPLP substrate binding regions identified 
in PhyAsr. Numbers according to PhyAsr. Residues involved with substrate binding in 
the PhyAsr C252S:InsP6 complex structure are highlighted in bold and the P-loop (252 to 
259) and GA-loop (223 to 224) in light grey. The abbreviation, source, and GenBank 
accession  number  are  as  follows:  M.  mul (N),  M.  multacida N-terminal  repeat, 
ABA18187;  M.  mul (C),  M.  multacida C-terminal  repeat,  ABA18187;   S.  rum,  S.  
ruminantium,  AAQ13669;  D.  mag, Desulfovibrio  magneticus, BAH75179.1;  W.  cho, 
Waddlia chondrophila, ADI38881.1; S. tes, Synergistetes bacterium SGP1, CBL27809.1; 
S.  aur,  Stigmatella  aurantiaca,  ADO68848.1;  P.  syr,  Pseudomonas  syringae, 
EGH63066.1;  P.  aca,  Parachlamydia  acanthamoebae,  EFB40166.1;  M.  els, 
Megasphaera elsdenii,  ABC69358;  L. pne,  Legionella pneumophila,  ABQ56993.1;  D. 
inv,  Dialister  invisus,  EEW97655.1;  C. tet,  Clostridium tetani,  AAO36153.1;  C. pro, 
Candidatus  protochlamydia,  CAF24552.1;  A.  fer,  Acidaminococcus  fermentans, 
ADB48152.1.
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Figure 1.7:  Schematic representation of InsP6 interactions with the PhyAsr phosphoryl 
binding sites. View of the interactions between InsP6 and PhyAsr C252S (PDB: 3MMJ) 
shown as sticks with the binding sites (grey spheres) labelled Ps (scissile phosphate), Pa, 
Pa', Pb, Pb', and Pc for reference. P3 is bound in the Ps site and P2 in the Pa'. Residues that 
interact with the IP ligand are derived from the P-loop (yellow), GA-loop (cyan), Phy 
domain and penultimate helix (green). The nitrogens are shown as blue, oxygens are red 
and ligand carbons in grey.
Table 1.1:  Phosphoryl binding site residues as identified in the PhyAsr C252S:InsP6 
complex structure (PDB: 3MMJ).
Phosphoryl Binding Site Residue
Ps S252, Q253, A254, G255, V256, R258
Pa H224, G257, K312
Pa' R57, D153, K189, D223
Pb Y309
Pb' R68
Pc K189
Figure 1.8:  Schematic of the major dephosphorylation pathway of PhyAsr according to 
the simple PTPLP substrate specificity model base on the PhyAsr C252S:InsP6 complex 
structure; where Pa' can only accommodate an axial phosphoryl group (P2) or a hydroxyl 
(OH), and Pa and Pb are preferentially filled due to stronger interactions than Pb' or Pc. 
Binding sites Ps, Pa, Pa', Pb, Pb', and Pc  have P3, P4, P2, P5, P1 and P6, respectively.
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1.3 Goals and objectives
Ultimately,  we  aim  to  engineer  PTPLPs  by  rational  design  to  manipulate  the 
substrate specificity and produce alternate IP products (Lei et al., 2013). The engineered 
PTPLPs  can  then  be  used  for  large-scale  production  of  IPs.  To rationally  design  an 
enzyme, clear understanding of how the structure affects function is required. Therefore, 
the  aim  of  my  research  was  understanding  PTPLP  substrate  specificity  at  atomic 
resolution in  order  to  identify and understand the  structural  determinants  that  govern 
substrate specificity. To this end, I produced multiple complex structures of PTPLPs with 
different IPs. An examination and comparison of protein:substrate interactions in these 
structures  enables  me  to  identify  novel  structure  determinants  that  allow PTPLPs  to 
follow  a  specific  pathway  when  hydrolyzing  InsP6. In  this  thesis,  I have  produced 
multiple  complex  structures  of  PhyAsr  with  less-phosphorylated  prokaryotic  and 
eukaryotic IPs, and the first PhyAmm complex structures which are with InsP6 and a less-
phosphorylated  eukaryotic  IP.  In  this  work,  prokaryotic  IPs  refer  to  intercellular  IPs 
which generally contain the axial P2, while eukaryotic IPs refer to intracellular IPs which 
generally do not contain the axial P2.
Chapter  2  describes  the  methods  used  to  produce  prokaryotic  IPs,  crystallize 
PhyAmm C250S/C548S, and soak PhyAsr C252S and PhyAmm C250S/C548S with IPs. 
Also included are the processing and refinement statistics describing the data quality, the 
quality of the resulting structures and the details of the structure analysis performed.
Chapter  3  describes  the  binding  of  prokaryotic  IPs,  Ins(1,2,4,6)P4 and 
Ins(2,4,5)P3, and eukaryotic IPs, Ins(1,3,4,5)P4 and Ins(1,4,5)P3, to PhyAsr C252S. The 
enzyme active  site  conformation  and phosphoryl  binding sites  remain  constant  in  all 
13
complexes,  including  the  published  apo  and  InsP6 structures.  Notably,  the  less-
phosphorylated IPs bind differently than InsP6. The less-phosphorylated IPs bind deeper 
in  the  active  site  resulting  in  unique  contacts  and unexpected  use  of  the  phosphoryl 
binding sites. Further, there is a difference in the binding of eukaryotic (lack the axial P2) 
and prokaryotic (contain the axial P2) IPs. The data presented in this chapter allows for 
revision  of  the  simple  substrate  specificity  model,  which  is  based  on  the  PhyAsr 
C252S:InsP6 complex  structure,  and  now  accounts  for  all  major  and  minor  PhyAsr 
pathway products.
Chapter 4 describes the first PhyAmm complex structures. The complex structures 
have subtle differences in dimer structure which give rise to different space groups. I 
demonstrate that in all space groups the active sites are identical, independent of whether 
the substrate is included during crystal growth or is soaked in after the crystal has been 
formed. In addition, we see that there are no active-site changes associated with binding 
of different ligands (InsP6 and Ins(1,3,4,5)P4) and that the active site of the C-terminal 
repeat is nearly identical to that of PhyAsr. PhyAmm has identical phosphoryl binding 
sites as PhyAsr and the revised substrate specificity model, which is consistent with the 
PhyAmm dephosphorylation pathway, can be applied to PhyAmm.
Finally, in Chapter 5 the simple PTPLP specificity model is revised based on the 
new  less-phosphorylated  complex  structures  to  better  fit  the  PTPLP pathways.  Also 
discussed are several unexpected features of these complex structures. These include the 
non-canonical binding of substrates to PhyAsr and the presence of an additional inorganic 
phosphate in the PhyAmm C250S/C548S:InsP6 complex. In closing, I consider models of 
substrate binding to the N-terminal repeat of PhyAmm.
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Chapter 2: Experimental Procedures
2.1 Ligand production and purification
InsP6 isolated from rice and premium Ins(1,4,5)P3 were purchased from Sigma-
Aldrich  and  Ins(1,3,4,5)P4 was  purchased from Echelon  Bioscience.  Prior  to  use  the 
ligands  were  dissolved  in  the  desired  buffer  for  hydrolysis  assays  or  crystallization 
experiments.
Hydrolysis of 50 mM InsP6 was performed using 1 μM PhyAsr. The reaction was 
performed at 20ºC in 100 mM NaAcetate (pH 5.0) and 300 mM NaCl. Following the 
appropriate,  empirically  determined  incubation  period,  the  reactions  were  stopped by 
quenching with 500 mM HCl. The samples were then analyzed by anion exchange HPLC 
(CarboPacTM PA-100, Dionex) as previously described with a post-column reaction [0.1 
% w/v Fe(NO3)3 and 2 % w/v HClO4 (0.2 mL/min)] followed at 290 nm to visualize the 
IP (Skoglund et al., 1998). To purify the IP, the same protocol was followed without the 
post-column reaction and the samples corresponding to the desired peak were collected. 
The IP was then precipitated by adding CaCl2 at a 10-fold excess and the pH adjusted to 
10.  The  precipitate  was  collected  by  centrifugation,  washed  with  water  followed  by 
methanol and air dried. The precipitate was used as a solid or dissolved in desired buffer 
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for soaking experiments. The resulting substrates were Ins(1,2,4,6)P4 and Ins(2,4,5)P3 as 
determined by crystallographic methods.
2.2 Expression and purification of PhyA
The PhyA genes of S. ruminantium (phyAsr) and M. multacida (phyAmm) were 
previously  cloned  into  the  NdeI  site  of  the  pET28bKan expression  vector  (EMD 
Biosciences) to add an N-terminal 6x His tag (Puhl et al., 2007; Gruninger et al., 2009). 
The  inactive  mutants  phyAsr  C252S  and  phyAmm C250S/C548S  were  produced  by 
polymerase chain reaction (PCR) amplification as previously described (Puhl et al., 2007; 
Gruninger et al., 2009). Proteins were purified to homogeneity by metal chelating affinity 
(Ni+-NTA-agarose, Bio-Rad), cation exchange (Bio-Scale S Column, Bio-Rad) and size 
exclusion chromatography (S200, GE Healthcare) as previously described  (Puhl et al., 
2007;  Gruninger  et  al.,  2009).  PhyAsr  C252S was  dialyzed  into  20  mM ammonium 
bicarbonate (pH 8.0) and lyophilized. PhyAmm C252S/C548S was dialized into 100 mM 
Tris-Cl  (pH  8.0),  100  mM  NaCl,  1  mM  β-mercaptoethanol  (BME),  and  0.1  mM 
ethylenediaminetetraacetic acid (EDTA; pH 8.0) and 20 % v/v glycerol was added, then 
the protein was used immediately or stored at -80ºC.
2.3 Crystallization
2.3.1 PhyAsr C252S
Crystallization experiments  were conducted  at  room temperature  using  sitting-
drop vapour diffusion with drop ratios of 2 μL of 20 mg/mL protein solution to 2 μL of 
reservoir solution as previous described (Gruninger et al., 2008). After 30 days there were 
rod-like crystals  with approximate dimensions of 30  × 30  × 100 μm. PhyAsr C252S 
crystals  were  soaked  with  the  purified  Ins(1,2,4,6)P4,  Ins(2,4,5)P3,  commercial 
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Ins(1,3,4,5)P4 or Ins(1,4,5)P3. In all cases, the crystals were soaked with 5-15 mM ligand 
solutions for 5-15 minutes in the mother liquor with 22 % v/v gylcerol. The crystals were 
then flash frozen in liquid nitrogen.
2.3.2 PhyAmm C250S/C548S
Crystallization experiments  were conducted  at  room temperature  using  sitting-
drop vapour diffusion with drop ratios of 2 μL of 4.5 mg/mL protein solution to 2 μL of 
reservoir  solution.  Crystals  for  soaking  experiments  were  grown  in  1-11  %  w/v 
polyethylene glycol  (PEG) 8000, 100 mM Tris-Cl (pH 8.0),  1 mM BME, 3-5 % v/v 
ethylene glycol, 20 % v/v glycerol (from protein buffer) and 100 μL of glycerol was 
added to the reservoir solution after the drops had been mixed. Co-crytals were grown in 
the above conditions supplemented with 10 mM InsP6. After 10 days there were rod-like 
crystals with approximate dimensions of 100 × 100 × 500 μm. The crystals were soaked 
with 10 mM InsP6 or Ins(1,3,4,5)P4 for 5-15 minutes in the mother liquor and flash frozen 
in liquid nitrogen. The co-crystals were flash frozen directly from the drop.
2.4 Data collection and image processing
Diffraction data (λ = 0.97934 Å) was collected from frozen crystals (100 K) using 
a  Rayonix  MX300  CCD detector  at  beamline  08ID-1  located  at  the  Canadian  Light 
Source  (CLS;  Saskatoon,  SK,  Canada).  All  diffraction  image  data  was  interactively 
processed with MOSFLM, prior to scaling and merging within AIMLESS of the CCP4 
program  suite  (version  6.3.0),  as  both  PhyAsr  and  PhyAmm  complex  crystals  are 
radiation sensitive (Leslie, 1992; CCP4, 1994; Evans, 2006; Evans, 2011). For PhyAmm 
C250S/C548S complex crystals, anisotropic diffraction prevents automated processing of 
the  data.  In  these  cases,  adjustments  to  the  peak  integration  profile  and  mosaicity 
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facilitated  data  processing.  Key  data  processing  statistics  for  all  PhyAsr  C252S  and 
PhyAmm C250S/C548S complex structures are presented in Table 2.1 and Table 2.2, 
respectively. 
Table 2.1. Data collection statistics for the X-ray crystallographic structures of PhyAsr 
C252S in complex with Ins(1,2,4,6)P4, Ins(2,4,5)P3, Ins(1,3,4,5)P4, and Ins(1,4,5)P3.1
Ins(1,2,4,6)P4 Ins(2,4,5)P3 Ins(1,3,4,5)P4 Ins(1,4,5)P3
Space group P21 P21 P21 P21
a, b, c (Å) 46.1, 138.2, 80.9 46.1, 137.3, 80.2 45.8, 138.1, 80.6 46.0, 137.7, 80.0
β (˚) 102.5 103.0 102.3 102.4
Wavelength (Å) 0.97949 0.97949 0.97934 0.97934
Resolution (Å) 32 – 1.90 (1.94 – 1.90)
43 – 1.75
(1.78 – 1.75)
43 – 1.95
(1.99 – 1.95)
46 – 2.00
(2.05 – 2.00)
Observed reflections 160 964 193 735 267 666 216 990
Unique reflections 66 642 81 119 71 167 65 377
Completeness (%) 86.0 (89.4) 83.3 (66.1) 100 (100) 99.9 (99.9)
Redundancy 2.4 (2.3) 2.4 (1.7) 3.8 (3.7) 3.3 (3.3)
Rmergea (%) 14.1 (46.5) 9.2 (4.43) 14.0 (64.5) 12.7 (63.6)
I/σI 3.5 (1.3) 7.4 (1.7) 5.8 (1.8) 5.2 (1.4)
1 values in parenthesis are for the highest resolution shell
a
 Rmerge = Σ | Ihkl - <Ihkl> | / Σ I hkl
2.5 Structure refinement and model validation
Phases derived from the PhyAsr C252S:InsP6 complex structure (PDB: 3MMJ) 
and wild-type PhyAmm (PDB: 3F41) were used to solve the structures by molecular 
replacement.  Continuous  electron  density  was  observed  for  amino  acids  33-346  of 
PhyAsr  C252S  and  46-636  of  PhyAmm C250S/C548S,  with  the  remaining  residues 
located  at  the  termini  assumed  to  be  disordered.  Refinement  was  performed  using 
REFMAC (version 5.7) within the CCP4 program suite while interactive fitting of the 
model and density were performed in COOT (version 0.6.2) (CCP4, 1994; Emsley et al., 
2010). PROCHECK was used throughout refinement to assess the stereochemistry of the 
model  and  to  determine  the  Ramachandran  distribution  (Vaguine  et  al.,  1999). 
18
Refinement  statistics  for  PhyAsr  C252S  and  PhyAmm  C250S/C548S  structures  are 
shown in Table 2.3 and Table 2.4, respectively. 
Table 2.2. Data collection statistics for the X-ray crystallographic structures of PhyAmm 
C250S/C548S in complex with InsP6 and inorganic phosphate in the P1 and C2 space 
groups, and Ins(1,3,4,5)P4.1
InsP6 and Pi InsP6 and Pi Ins(1,3,4,5)P4
Space group P1 C2 P1
a, b, c (Å) 73.2, 86.9, 125.8 156.9, 73.5, 74.2 73.9, 86.8, 124.3
α, β, γ (˚) 107.4, 91.5, 90.1 90.0, 91.6, 90.0 107.3, 91.7, 90.0
Wavelength (Å) 0.97949 0.97949 0.97934
Resolution (Å) 46 – 2.00 (1.83 – 1.80)
55 – 2.10
(2.03 – 2.00)
47 – 1.80
(2.16 – 2.10)
Observed reflections 335 439 192 963 525 829
Unique reflections 167 323 48 998 246 889
Completeness (%) 83.7 (80.0) 99.5 (98.9) 90.4 (55.6)
Redundancy 2.0 (1.9) 3.9 (3.9) 2.1 (2.0)
Rmergea (%) 10.1 (58.2) 11.2 (116.2) 10.2 (42.8)
I/σI 4.3 (1.8) 7.0 (1.2) 3.7 (1.2)
1 values in parenthesis are for the highest resolution shell
a
 Rmerge = Σ | Ihkl - <Ihkl> | / Σ I hkl
2.5.1 Ligand libraries
Ligand  libraries  were  not  available  for  Ins(1,2,4,6)P4,  Ins(2,4,5)P3,  and 
Ins(1,4,5)P3, therefore, they had to be created. All libraries were created from the InsP6 
(IHP) parent file with the restraints for the hydroxyl groups defined from the inositol-
1,3,4,5-tetrakisphosphate (4IP) library. A new library was also created for Ins(1,3,4,5)P4 
using the same protocol, which resulted in additional restraints relative to the current 4IP 
library.
2.6 Structure analysis and representation
Least  squares  (LSQ)  superpositions  of  the  main-  and  side-chain  residues  of 
PhyAsr C252S and PhyAmm C250S/C548S were performed using LSQKAB from the 
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CCP4 program suite (CCP4, 1994). The protein structure comparison of PhyAsr C252S 
was performed on amino acids 34 to 346 with 1252 and 1297 non-hydrogen atoms used 
in the main- and side-chain pairwise comparison, respectively.  Pairwise comparisons of 
PhyAmm were performed on the  main-chain atoms of  amino acids  47 to  636 (2360 
atoms), 47 to 342 (1184 atoms), and 343 to 636 (1176 atoms) for the monomer, N- and C-
terminal  repeats,  respectively.  Active-site  superpositions  utilized  residues  making 
contacts with the ligand as determined by the CCP4 program CONTACT and choosing
Table  2.3. Refinement  statistics  of  PhyAsr  C252S  in  complex  with  Ins(1,2,4,6)P4, 
Ins(2,4,5)P3, Ins(1,3,4,5)P4, and Ins(1,4,5)P3.1 
Ins(1,2,4,6)P4 Ins(2,4,5)P3 Ins(1,3,4,5)P4 Ins(1,4,5)P3
Space group P21 P21 P21 P21
Resolution (Å) 32 – 1.90 43 – 1.75 43 – 1.95 46 – 2.00
No. reflections work set 62 533 73 061 66 838 61 430
No. reflections test set 2009 4023 2147 1956
Rworka (%) 18.6 14.9 16.7 19.3
Rfreea (%) 22.1 18.5 20.2 22.7
Protein atoms 5 173 5 179 5 148 5 112
Solvent atoms 797 866 676 449
Ligand atoms 68 82 80 72
Wilson B (Å2) 21.5 18.4 23.2 30.8
Average protein B (Å2) 20.4 17.1 22.2 30.5
Average main-chain B (Å2) 18.0 14.5 19.0 28.1
Average side-chain B (Å2) 25.4 28.9 28.9 36.1
Average solvent B (Å2) 29.1 28.9 30.7 35.0
Average ligand B (Å2) 30.2 27.5 33.4 39.4
RMSD Bonds (Å) 0.011 0.010 0.012 0.010
RMSD Angle (˚) 1.491 1.477 1.417 1.408
Ramachandran distribution
Most favoured (%) 92.3 93.5 92.0 90.9
Additionally allowed (%) 7.3 6.4 7.5 8.4
Generously allowed (%) 0.4 0.2 0.5 0.7
Disallowed (%) 0.0 0.0 0.0 0.0
1 values in parenthesis are for the highest resolution shell
a
 R = Σhkl | | Fobs | - | Fcalc | | / Σhkl | Fobs |
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the residues on either side if they displayed good electron density (at 1  σ in the 2Fo-Fc 
map) and no alternate conformations  (CCP4, 1994). The residues in the PhyAsr C252S 
active-site LSQ superposition were from the PTP domain (56 to 58), Phy domain (152 to 
154, 189 to 190), GA-loop (221 to 226), P-loop (249 to 262), and the penultimate helix 
extension (304 to 309, 311 to 313). The numbers of non-hydrogen atoms used in the 
main- and side-chain pairwise comparison were 148 and 182, respectively. Equivalent 
residues in the PhyAmm C250S/C548S active site LSQ superpositions were from the
Table 2.4. Refinement statistics of PhyAmm C250S/C548S in complex with InsP6 and 
inorganic phosphate, and Ins(1,3,4,5)P4.1 
InsP6 and Pi InsP6 and Pi Ins(1,3,4,5)P4
Space group P1 C2 P1
Resolution (Å) 46 – 2.00 55 – 2.10 47 – 1.80
No. reflections work set 150 536 46 512 236 720
No. reflections test set 8387 2482 5067
Rworka (%) 19.1 20.2 20.0
Rfreea (%) 24.5 25.2 24.0
Protein atoms 19 257 4809 19 276
Solvent atoms 1 588 342 2 293
Ligand atoms 340 77 242
Wilson B (Å2) 31.6 42.4 14.8
Average protein B (Å2) 31.0 42.1 13.9
Average main-chain B (Å2) 28.6 39.7 12.7
Average side-chain B (Å2) 36.4 47.2 16.9
Average solvent B (Å2) 34.6 41.9 22.0
Average ligand B (Å2) 39.5 59.9 27.4
RMSD Bonds (Å) 0.010 0.009 0.007
RMSD Angle (˚) 1.376 1.377 1.248
Ramachandran distribution
Most favoured (%) 88.2 85.5 88.3
Additionally allowed (%) 10.8 12.6 10.6
Generously allowed (%) 0.6 1.1 0.8
Disallowed (%) 0.4 0.8 0.2
1 values in parenthesis are for the highest resolution shell
a
 R = Σhkl | | Fobs | - | Fcalc | | / Σhkl | Fobs |
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PTP domain (350 to 352), Phy domain (448 to 450, 484 to 486), GA-loop (517 to 522), 
P-loop  (545  to  565),  and the  penultimate  helix  extension  (584 to  586,  599  to  605), 
resulting  in  184  and  260  non-hydrogen  main-  and  side-chain  atoms,  respectively. 
Structural comparisons of the PhyAmm dimers were performed by LSQ superposition 
using GESAMT over 1180 Cα atoms and the dimer interfaces identified by PISA (Protein 
Interfaces, Surfaces, and Assemblies) (CCP4, 1994). 
To  compare  ring-shift  difference  in  the  PhyAsr  C252S  structures,  LSQ 
superposition of main-chain atoms of the P-loop and flanking residues (249 to 269) were 
carried out in COOT (version 0.6.2) and then the resulting ligand coordinates were used 
as input for GEOMCALC in the CCP4 program suite (CCP4, 1994; Emsley et al., 2010). 
The distances between the 6-carbon of InsP6 and the structurally equivalent carbons in the 
active  site  were  determined  as  well  as  the  angle  between  the  carbon  ring  planes. 
Superpostions  of  the  PhyAsr  C252S  complex  structures  on  the  C-terminal  repeat  of 
molecule A of the PhyAmm C250S/C548S Ins(1,3,4,5)P4 structure was performed using 
COOT (version 0.6.2) with amino acids 249 to 269, and 545 to 565, respectively (CCP4, 
1994; Emsley et al., 2010). To determine the structurally equivalent active-site residues of 
PhyAsr, and PhyAmm N- and C-terminal repeats, amino acids 249 to 269, 247 to 267, 
and  545  to  565,  respectively,  were  superposed  in  COOT  (version  0.6.2)  and  then 
compared.
Unless indicated otherwise, figures were prepared with CCP4mg (version 2.6.2) 
and the two dimensional  representations  of  contacts  prepared  using  LigPlot+ (version 
v.1.4.4; European Bioinformatics Institute) (Laskowski and Swindells, 2011; McNicholas 
et al., 2011).
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Chapter  3:  Examination  of  Substrate  Binding  Provides  a  Rationale  for  the 
Dephosphorylation Pathway of PhyAsr
3.1 Structures of PhyAsr C252S in complex with less-phosphorylated myo-
inositol phosphates
As a precursor to the rational design of PTPLPs with desired IP specificity, I have 
determined high-resolution  structures  of  the  inactive  C252S  mutant  of  PhyAsr  in 
complex  with  Ins(1,2,4,6)P4,  Ins(2,4,5)P3,  Ins(1,3,4,5)P4,  and  Ins(1,4,5)P3.  These 
structures  provide  the  first  examples  of  PhyAsr  interactions  with  less-phosphorylated 
structures  and  have  allowed  me  to  identify  structural  determinants  unique  to  less-
phosphorylated  substrates. The  complex  structures  have  been  solved  at  resolutions 
between 1.75 and 2.00 Å. Analysis of the 2Fo-Fc omit and difference density maps clearly 
identified ligands bound in the active sites displaying excellent electron density that are 
present  at  occupancies  between 80 % and 100 % (Figure  3.1).  The prokaryotic  IPs, 
Ins(1,2,4,6)P4 and  Ins(2,4,5)P3,  were  present  at  occupancies  of  100  %  and  80  %, 
respectively,  with  P6  of  Ins(1,2,4,6)P4 refined  as  an  alternate  conformation.  The 
eukaryotic  IPs,  Ins(1,3,4,5)P4 and  Ins(1,4,5)P3,  were  both  present  at  100  %  with 
Ins(1,4,5)P3 refined in two conformations.
Analysis of the difference density maps of Ins(1,2,4,6)P4 and Ins(1,4,5)P3 while 
refining  the  structures  demonstrated  negative  difference  density  for  P6  and  P5, 
23
respectively, when P1 is in the Ps site. In both cases, it was clear that there were alternate 
conformations, but in the case of Ins(1,2,4,6)P4 a rotation of P6 torsion angle explained 
the negative difference density of P6 and additional positive difference density in the 
active  site.  However,  the  Ins(1,4,5)P3 structure  resulted  in  the  ligand binding in  two 
conformations  with  P1  and  P4  bound  in  the  Ps site  at  60  % and  40  % occupancy, 
respectively, to explain the difference density maps. In the case of Ins(2,4,5)P3 there was 
negative  difference  density  present  for  all  atoms,  with  the exception  of  P4,  which  is 
bound to the Ps site, when it was refined at full occupancy. A similar observation was 
made for the PhyAsr C252S:InsP6 structure and was resolved by modeling an inorganic 
phosphate in the active site at an occupancy of 25 % and InsP6 at 75 % (Gruninger et al., 
2012).  Here,  I  am able to  account for the electron difference density  using the same 
approach. PhyAsr C252S binds Ins(2,4,5)P3 or inorganic phosphate at occupancies of 80 
% and 20 %, respectively. Ins(1,3,4,5)P5 is only present in one conformation at 100 % 
occupancy. 
3.1.1 Comparison of complex protein structures with the wild-type PhyAsr and 
PhyAsr C252S:InsP6 structures
PhyAsr C252S complex crystals were produced in the crystallization conditions 
used by Gruninger et al. (2012) and resulted in comparable unit cell parameters, crystal 
contacts and resolutions to the published structure. Analysis by LSQ superposition of the 
monomer main- and side-chain atoms of the different structures demonstrated they all 
have RMSDs of 0.26  Å or lower and 0.95  Å or lower,  respectively (Table 3.1).  The 
absolute error of X-ray crystallographic coordinates at this resolution is approximately 
0.2  Å,  therefore  RMSDs  below  0.2  Å  are  essentially  identical.  Generally,  when
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(a)           (b)
     
(c)           (d)
     
Figure 3.1:  PhyAsr C252S in complex with less-phosphorylated substrates fit  to the 
electron density (Sigma-A weighted 2Fo-Fc) associated with the active site, contoured at 
1σ (blue).  Electron density of the prokaryotic IPs (a) Ins(1,2,4,6)P4, (b) Ins(2,4,5)P3 from 
PhyAsr's known dephosphorylation pathway where both have P4 in the Ps site. Electron 
density of the eukaryotic IPs (c) Ins(1,3,4,5)P4 with P1 in the Ps site, and (d) Ins(1,4,5)P3 
with alternate conformations that have P1 or P4 in the Ps site. Phosphoryl binding sites 
are labelled as in Figure 1.6, and highlight specific interactions between PhyAsr C252S 
and these substrates. Ligands and protein are shown as sticks with oxygens shown in red, 
nitrogens in blue, phosphorus in orange, and carbons are grey. 
comparing main- and side-chain RMSDs one would expect the side-chain RMSDs to be 
about two or three times larger than the main-chain RMSDs. Therefore, the low main-
chain RMSDs indicate that there are no large-scale conformational changes associated 
with substrate binding which is consistent with previous structural studies  (Chu et al., 
2004; Gruninger et  al.,  2008). The relatively low side-chain RMSDs are  attributed to 
surface residues adopting multiple conformations or poor electron density as opposed to 
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large-scale  conformational  changes.  Overall,  the  InsP6 and  apo (no  IP ligand  bound) 
PhyAsr structures are most similar, while the least-phosphorylated ligands display the 
greatest divergence as judged by LSQ superposition. 
Table 3.1:  Pairwise RMSD comparison of the PhyAsr C252S monomer alone and in 
complex with IPs. RMSDs of the monomer main- (mc) and side-chain (sc) atoms (Å) are 
shown. LSQ superposition of 1252 and 1297 atoms was performed for the main- and 
side-chain, respectively.
InsP6 Ins(1,2,4,6)P4 Ins(2,4,5)P3 Ins(1,3,4,5)P4 Ins(1,4,5)P3
mc sc mc sc mc sc mc sc mc sc
Apo (2PSZ) 0.14 0.69 0.17 0.43 0.18 0.84 0.19 0.84 0.22 0.63
InsP6 (3MMJ) 0.19 0.70 0.22 0.94 0.19 0.95 0.23 0.73
Ins(1,2,4,6)P4 0.21 0.81 0.18 0.79 0.24 0.64
Ins(2,4,5)P3 0.21 0.78 0.26 0.88
Ins(1,3,4,5)P4 0.20 0.90
3.1.2 Less-phosphorylated myo-inositol phosphates binding to PhyAsr C252S
A comparison of the monomer and active-site RMSDs reveals that the active-site 
RMSDs are comparable or lower. The RMSDs for the main- and side-chain atoms of the 
active site are 0.20 Å or lower and 0.58 Å or lower, respectively (Table 3.2). The active-
site residues are amongst the most highly conserved within the family and are expected to 
have lower RMSDs if the enzyme active site is preformed (no conformational change 
upon IP binding)  as  previously  observed  (Gruninger  et  al.,  2009;  Puhl  et  al.,  2009). 
Overall, the structures of PhyAsr C252S with prokaryotic ligands are most similar to the 
InsP6 structure, and while the eukaryotic ligand structures have slightly larger RMSDs, 
these structures are essentially the same. 
When bound to the active-site of PhyAsr C252S, all the IPs are in the low-energy 
chair  conformation  with  five  equatorial  hydroxyl/phosphoryl  groups.  However,  the 
inositol  rings  of  the  less-phosphorylated  IPs  bind  differently  in  the  active  site  in
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Table 3.2:  Pairwise RMSD comparison of the PhyAsr C252S active-site alone and in 
complex with IPs. Main- (mc) and side-chain (sc) RMSDs (Å) of the active-site residues 
are shown. LSQ superposition of 148 and 182 atoms was performed for the main- and 
side-chain, respectively.
InsP6 Ins(1,2,4,6)P4 Ins(2,4,5)P3 Ins(1,3,4,5)P4 Ins(1,4,5)P3
mc sc mc sc mc sc mc sc mc sc
Apo (2PSZ) 0.13 0.36 0.19 0.39 0.13 0.54 0.20 0.58 0.18 0.43
InsP6 0.14 0.17 0.08 0.46 0.17 0.51 0.15 0.24
Ins(1,2,4,6)P4 0.12 0.48 0.15 0.49 0.15 0.20
Ins(2,4,5)P3 0.14 0.39 0.14 0.50
Ins(1,3,4,5)P4 0.14 0.49
comparison with InsP6. The inositol rings are rotated by 180°  resulting in the opposite 
face contacting the enzyme (Figure 3.2) and the inositol rings are tilted towards the GA-
loop. The inositol ring also binds differently in the prokaryotic and eukaryotic complex 
structures (Figure 3.2c-d). The distance between C6 of the inositol ring of InsP6 (furthest 
from the scissile phosphate) and structurally equivalent positions in the prokaryotic IPs 
are shifted between 0.46 and 1.13 Å, whereas the eukaryotic IPs are shifted between 1.60 
and 1.75 Å (Table 3.3). Relative to InsP6,  the prokaryotic ring plane angle is smaller 
(13.22 and 25.47º), and the distance between the centre of mass of each plane shorter 
(0.50 and 0.80 Å). The eukaryotic ring plane angles are larger (29.35 and 40.87º), and the 
distances between the centre of mass of each plane are larger (1.26 and 1.41 Å) relative to 
InsP6. These results indicate the less-phosphorylated IPs bind more deeply in the active 
site  in  comparison  with  highly-phosphorylated  substrates.  Overall,  the  prokaryotic 
inositol  rings  are  positioned  closer  to  the  InsP6 than  the  eukaryotic  inositol  rings.  A 
detailed list is found in Table 3.3.
Each ligand's scissile phosphate forms extensive main-chain interactions with the 
P-loop as is consistent with previous structural studies (Tables 3.4 and 3.5)  (Chu et al., 
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2004; Gruninger et al., 2012). The P-loop, GA-loop and K312 are the only interactions 
that originate from the PTP domain. The remaining contacts are mediated by side-chains 
of  residues  derived  from  the  Phy  domain  and  the  Phy-specific  extension  of  the 
penultimate helix; the same applies to the InsP6 structure. The InsP6 ligand is the most 
highly-phosphorylated IP complex structure to date and makes the greatest number of  
   (a)                                                   (b)
     
   (c)                                                   (d)
         
Figure 3.2:  Inositol ring conformation differences of InsP6, prokaryotic, and eukaryotic 
IPs in the active site of PhyAsr C252S. (a) Front and (b) top view (relative to the GA-
loop) of the carbon rings of InsP6 (blue),  Ins(1,2,4,6)P4 (green),  Ins(2,4,5)P3 (purple), 
Ins(1,3,4,5)P4 (orange), and Ins(1,4,5)P3 (red) from a LSQ superposition of the P-loop 
and flanking residues main-chain atoms of PhyAsr. InsP6 with the (c) prokaryotic and (d) 
eukaryotic inositol rings coloured as in (a) viewed with the GA-loop to the right. These 
figures demonstrate that the less-phosphorylated IPs bind deeper in the active site than 
InsP6 and the eukaryotic IPs bind deeper than the prokaryotic IPs.
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Table  3.3:   Less-phosphorylated  IP ring  shift  angles  and  distances  relative  to  InsP6 
derived from  a LSQ superposition of PhyAsr's P-loop and flanking residues. Distance 
between C6 of InsP6 and the structurally equivalent carbons in the active site, the angles 
between the plane of the 6-carbon rings and the distance of the centre of mass of the 
carbon rings are shown. 
Ins(1,2,4,6)P4
Ins(2,4,5)P3 Ins(1,3,4,5)P4
Ins(1,4,5)P3
A B A B
C6 distance
Plane angle Δ
Plane distance
0.84 Å
20.82 ˚
0.74 Å
1.13 Å
25.47 ˚
0.80 Å 
0.46 Å
13.22 ˚
0.50 Å
1.61 Å
29.93 ˚
1.34 Å
1.75 Å
40.87 ˚
1.41 Å
1.60 Å
29.35 ˚
1.26 Å
contacts with the active site by virtue of its size. Consequently, the less-phosphorylated 
ligands  typically  utilize  a  subset  of  previously  identified  contacts.  Unlike  the  InsP6 
structure  which  makes  contacts  with  the  solvent-exposed  phosphoryl  groups  that  are 
largely mediated by ordered waters, there are multiple direct contacts between the protein 
and phosphoryl groups in the less-phosphorylated IP structures due to the shift in IP ring 
position (Figures 3.3 and 3.4). 
Comparisons of the prokaryotic IP and InsP6 complex structures highlight several 
unique contacts that  are  specific  to  the less-phosphorylated structures.  The conserved 
K305 residue is a component the Pc site in each of the less-phosphorylated structures and 
directly  interacts  with  phosphoryl  or  hydroxyl  groups occupying equivalent  positions 
(Figure 3.3, Table 3.4). In the InsP6 structure, K305 interacts with ordered waters that 
make contacts to the phosphoryl groups in the Pc site. A second interaction unique to 
these less-phosphorylated complexes involves A254, which forms a hydrogen-bond with 
the C3-hydroxyl of the prokaryotic IPs shifted ring. Despite the identified differences in 
IP ring positions, all remaining contacts between the enzyme and less-phosphorylated IPs 
utilize residues previously assigned to phosphoryl binding sites. The phosphoryl groups 
of  Ins(1,2,4,6)P4 occupy the Ps (P4), Pb (P6), Pc (P1) and Pa' (P2) binding sites, while 
Ins(2,4,5)P3 occupies  the  Ps (P4),  Pa (P5)  and  Pa' (P2)  binding  sites.  An  important 
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consequence of the difference in IP ring position, is the ability of phosphoryl groups that 
are not adjacent to the Ps site to occupy the Pa' site instead of the Pb' site predicted by the 
simple specificity model. This allows these phosphoryl groups to vacate the Pb' binding 
site which is characterized by water-mediated interaction in the InsP6 complex structure 
and enter the Pa' site where several direct contacts are made with the conserved  R57. 
Table 3.4:  PhyAsr C252S contacts with InsP6 and the prokaryotic IPs Ins(1,2,4,6)P4 and 
Ins(2,4,5)P3. Contact distances (< 3.4  Å) between PhyA and the ligand phosphoryl and 
hydroxyl groups are shown. Bolded distances are main-chain interactions.
InsP6
Ins(1,2,4,6)P4 
(A)
Ins(1,2,4,6)P4 
(B) Ins(2,4,5)P3
R57 Pa'
P2
P1
3.09
2.83
3.26
3.36
P2 3.163.14 P2
3.14
3.05 P2
2.82
3.07
D153 Pa' P2 3.12 P2 3.32
K189 Pa'/Pc P6 3.10 P1 3.12
P2
P1
3.09
2.38 P2 2.88
D223 Pa' P2
2.21
3.26
3.33
P2
P4
2.49
3.38 P2 2.89 P2 2.68
H224 Pa P4 2.99
P2
P6
3.27
2.57
P2
P5
3.28
2.92
S252 Ps P3 2.54 P4 2.23 P4
3.15
2.24 P4 2.27
E253 Ps P3 2.93 P4 3.08 P4 3.07 P4 3.19
A254 Ps P3 3.13 O3 3.04
O3
P4
2.89
3.39
3.28
O3 3.08
G255 Ps P3 2.85 P4 3.09 P4 2.65 P4 2.96
V256 Ps P3 2.97 P4 2.82 P4 2.80 P4 2.93
G257 Pa P4 3.25 O5 3.33 O5P4
2.69
3.21 P5 3.37
R258 Ps P3
2.85
2.87 
2.91 
P4
2.93
3.25
3.05
P4
2.95
2.86
2.82
P4
2.82
2.94
2.94
K305 Pb/Pc
P1
P6
2.75
2.49 P1
2.19
3.31
O6
P5
2.90
2.58
Y309 Pb
P4
P5
3.24
3.17 P6
1.99
3.27 P6 2.31
K312 Pa P4 2.85 P5 2.91
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(a)            (b)
 
(c)            (d)
 
(e)            (f)
 
Figure  3.3:   Stick  diagrams  of  the  observed  conformations  of  less-phosphorylated 
prokaryotic IPs bound in the active site of PhyAsr C252S. Residues that interact with the 
IP  ligand  are  derived  from  the  P-loop  (yellow),  GA-loop  (cyan),  Phy  domain  and 
penultimate helix (green). Ins(1,2,4,6)P4 with P4 bound in the Ps site with P6 in alternate 
conformations at occupancies of 60 % (a-b) and 40 % (c-d).  (e-f) Ins(2,4,5)P3 with P4 
bound in the Ps site at full occupancy. (b, d and f) Two-dimentional representation of the 
contacts made by PhyAsr C252S to each of the phosphoryl groups. Oxygens shown in 
red, nitrogens in blue, phosphorus in orange, and carbons are grey or black.
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Comparisons  of  eukaryotic  IPs  and the  InsP6 complex structures  yield  similar 
conclusions. The phosphoryl groups of the Ins(1,3,4,5)P4 ligand occupy the Ps (P1), Pb 
(P5), Pc (P4) and Pa' (P3) binding sites, utilizing the same phosphoryl binding sites as the 
prokaryotic Ins(1,2,4,6)P4 (Figure 3.4, Table 3.5). Interestingly, the equatorial P3 is able 
to  occupy  the  Pa' binding  site  similarly to  the  axial  P2  of  the  less-phosphorylated 
prokaryotic  IPs.  This  accounts  for  the  systematic  difference  in  the  IP ring  position 
between less-phosphorylated eukaryotic and prokaryotic IPs.  Apparently, the absence of 
an axial (P2) phosphoryl group in the Pa' site allows the eukaryotic IPs to undergo a larger 
shift in IP ring position. The Ins(1,4,5)P3 ligand binds in two alternate conformations in 
the active site. In one conformation, the phosphoryl groups occupy the Ps (P4), Pa (P5) 
and Pa' (P1) binding sites. This use of phosphoryl binding sites is similar to that observed 
in the prokaryotic Ins(2,4,5)P3 complex structure where the Ps and Pa sites are filled with 
identical phosphoryl groups. In the second Ins(1,4,5)P3 conformer, P1 is located within 
the Ps site while P4 and P5 occupy the Pb and Pc sites, respectively. This conformation 
places the axial C2 hydroxyl in direct contact with the invariant D223 general acid.  As 
all  prokaryotic  IPs  contain  an  axial  P2,  steric  clashes  prevent  prokaryotic  IPs  from 
binding in an equivalent manner. 
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Table 3.5:   PhyAsr C252S contacts with InsP6 and the eukaryotic IPs Ins(1,3,4,5)P4 and 
Ins(1,4,5)P3. Contact distances (<3.4  Å) between PhyA and the ligand phosphoryl and 
hydroxyl groups are shown. Bolded distances are main-chain interactions.
InsP6 Ins(1,3,4,5)P4 Ins(1,4,5)P3 (A) Ins(1,4,5)P3 (B)
R57 Pa'
P2
P1
3.09
2.83
3.26
3.36
P3
3.13
3.23
2.79
D153 Pa' P2 3.12
K189 Pa'/Pc P6 3.10
P3
P4
2.62
3.02 P4
3.07
3.31 P1
3.27
3.09
D223 Pa' P2
2.21
3.26
3.33
P3 3.102.89 O3 3.28 O2
2.96
3.04
H224 Pa P4 2.99
P3
P5
3.01
2.69 P5 3.25
S252 Ps P3 2.54 P1 2.49 P1 2.16 P4 2.47
E253 Ps P3 2.93 P1 3.01 P1 2.89 P4 3.05
A254 Ps P3 3.13 P1 3.17 P1 3.24 P4 3.15
G255 Ps P3 2.85 P1 2.93 P1 2.94 P4 2.68
V256 Ps P3 2.97 P1 2.61 P1 2.87 P4 2.60
G257 Pa P4 3.25 O6 3.07
P1
O6
3.37
2.94 P5
3.25
3.32
3.38
R258 Ps P3
2.85
2.87 
2.91 
P1
2.92
3.06
2.98
P1
2.75
2.80
2.85
P4
2.97
3.03
2.74
K305 Pb/Pc
P5
P4
2.33
3.19
2.35
2.32
P4 2.752.54 P1
2.54
2.47
Y309 Pb
P4
P5
3.24
3.17 P5
2.27
3.12 P5
2.85
2.67
K312 Pa P4 2.85 P5 2.47
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(a)            (b)
(c)            (d)
(e)            (f)
Figure  3.4:   Stick  diagrams  of  the  observed  conformations  of  less-phosphorylated 
eukaryotic IPs bound in the active site of PhyAsr C252S. (a-b) Ins(1,3,4,5)P4 bound with 
P1 bound to the Ps site at full occupancy. Alternate conformations of Ins(1,4,5)P3 with (c-
d) P1 and (e-f) P2 bound to the Ps site at occupancies of 60 % and 40 %, respectively. 
(b,d and  f) Two-dimensional representation of the contacts made by PhyAsr C252S to 
each of the phosphoryl groups. Coloured as in Figure 3.3.
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3.2 Discussion
3.2.1 Revised specificity model for PhyAsr binding less-phosphorylated myo-
inositol phosphates
The model based on the  Gruninger et al.  (2012) PhyAsr C252S:InsP6 complex 
structure rationalizes the observed PhyAsr specificity and assumes all substrates bind to 
the enzyme in identically or closely similar ring positions. Further, in this model, steric 
conflicts prevent the relatively strong interacting Pa' site from binding all but the axial P2 
or a hydroxyl group, which explains the enzyme's strict specificity for removing P3 of 
InsP6. Finally, this simple model suggests interactions in the Pa phosphoryl binding sites 
are relatively strong with many direct contacts in comparison to interactions furthest from 
the scissile phosphate that have few contacts (the Pb, Pb' and Pc sites). This simple model 
is  consistent with the hydrolysis  of InsP6 by the major pathway.  Here, I  have clearly 
shown the  inositol  ring in  all  PhyAsr C252S InsP4 and  InsP3 complex structures  are 
shifted up to 1.4 Å deeper into the active site and undergo a 180° rotation in comparison 
to InsP6 (Figure 3.2, Table 3.3). 
I have demonstrated that the active site is nearly identical in each of the complex 
structures, therefore the phosphoryl binding sites are the same. Due to the steric clashes 
between the axial P2 and D223, InsP6 cannot bind deeper into the active site, while in the 
less-phosphorylated  IP  structures,  this  clash  is  not  present.  Additionally,  the  less-
phosphorylated IP ring positions allow for phosphoryl groups that are not adjacent to the 
scissile phosphate to bind in the Pa' site (Figure 3.5). Therefore, the Pa' site is not restricted 
to  an axial  phosphoryl  or  hydroxyl  group adjacent  to  the scissile  phosphate for less-
phosphorylated  IPs,  as  is  suggested  by  the  PhyAsr  C252S:InsP6 complex  structure. 
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Combining this novel structural information with the simple substrate specificity model 
produces  a  revised  model.  The  first  rule  of  the  revised  model  is  the  Pa' site  can 
accommodate an axial phosphoryl group (P2), a hydroxyl group or a phosphoryl groups 
not adjacent to the scissile phosphate in less-phosphorylated IPs. The inositol ring shift of 
less-phosphorylated IPs also results in a movement of the phosphoryl groups bound to the 
Pb and Pc sites. The shift moves these phosphoryl groups deeper in the binding pocket and 
results  in  direct  contacts  with K305, in  contrast  to  the PhyAsr C252S:InsP6 complex 
structure where all contacts between the ligand and K305 are water-mediated (Gruninger 
et  al.,  2012).  This  suggests  the  conserved  K305  has  an  important  role  binding  less-
phosphorylated substrates. Assuming the Pa' site interactions are comparable to those of 
the Pa site,  based on the number of direct  contacts,  all  of my less-phosphorylated IP 
structures make optimal use of the Pa and Pa' sites.  Therefore, the second rule of the 
revised substrate  specificity model is  that the Pa and Pa' sites  would be preferentially 
filled.
3.2.2 Prokaryotic and eukaryotic myo-inositol ligand binding
I have clearly shown a difference in how InsP6 and the less-phosphorylated InsP4 
and InsP3 bind to PhyAsr C252S due to the IP ring positions (Figure 3.2, Table 3.3). 
Additionally, there is a clear difference between binding of prokaryotic and eukaryotic 
IPs. The prokaryotic IPs have a 0.5 to 0.8 Å shift from InsP6 and the eukaryotic IPs have 
shifts greater than 1.2 Å. When comparing the prokaryotic and eukaryotic IPs to InsP6, I 
observed tilts of 13 to 25° and 29 to 40°, respectively (Figure 3.6, Table 3.3). The ring-
shift differences between the prokaryotic and eukaryotic IPs are due to the presence or 
absence of the axial P2 in the Pa' site. The axial P2 prevents the prokaryotic IPs from
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  (a)      (b)
    
Figure  3.5:   Binding  of  InsP6 and  Ins(1,2,4,6)P4 to  PhyAsr  C252S  and  the  revised 
specificity model. (a) Top view of InsP6 (blue) and Ins(1,2,4,6)P4 (A conformation; green) 
bound to PhyAsr C252S's active site (P-loop in yellow, GA-loop in cyan, and protein in 
grey) with the top phosphate (opposite the Ps site) cut off. The Ins(1,2,4,6)P4 is bound 
deeper in the active site than InsP6 and clearly shows P2 bound in the Pa' site instead of 
the expected Pb' site.  (b) View of  the interactions between Ins(1,2,4,6)P4 and PhyAsr 
C252S with the binding sites labelled Ps, Pa, Pa', Pb, and Pc for reference, coloured as in 
Figure 3.3.
tilting  deeper  into  the  active  site  due  to  steric  clashes  that  are  not  present  with  the 
eukaryotic IPs. This suggests an InsP5 may undergo a modest ring shift relative to InsP6 
as it contains the axial P2. The differences in the magnitudes of ring position shifts are a 
novel feature of these enzymes and may contribute to the enzyme's ability to hydrolyze 
substrates in a specific order.
In  both  of  the  prokaryotic  IP  complex  structures,  we  observe  non-canonical 
binding. In my structures, P4 of Ins(1,2,4,6)P4 and Ins(2,4,5)P3 is in the Ps site while the 
dephosphorylation pathway predicts P6 and P5, respectively, to bind to the Ps site. In each 
case,  the  expected  ligand binding conformation  can  be  modelled  convincingly  in  the 
same location. Despite non-canonical binding in the enzyme active site, IP binding is 
consistent  with  both  the  simple  and  revised  specificity  models.  In  Chapter  5,  I  will 
discuss possible causes of the discrepancy between the IP binding orientations and the 
dephosphorylation pathway.
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Figure 3.6:  Binding differences of the prokaryotic and eukaryotic InsP4s. Top view of 
Ins(1,2,4,6)P4 (green) and Ins(1,3,4,5)P4 (orange) bound to PhyAsr C252S's active site 
(coloured as in Figure 3.5a) with the top phosphate (opposite the Pa' site) cut off. This 
shows the eukaryotic IPs have a larger tilt towards the GA-loop than the prokaryotic IPs.
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Chapter 4: Binding Site Analysis of PhyAmm C250S/C548S in Complex with Myo-
Inositol Phosphate Molecules
4.1 PhyAmm C250S/C548S in complex with myo-inositol phosphates
PhyAmm is the only known example of a PTPLP that is comprised of a tandem 
repeat, was a target of my studies (Nakashima et al., 2007; Gruninger et al., 2009). The 
individual repeats share 36 % sequence identity and have been shown to have different 
substrate specificities (Gruninger et al., 2009). In order to increase our understanding of 
the  structure  and substrate  specificity  of  this  family  of  enzymes  and to  improve the 
rational  design  process,  I  have  determined  the  first  atomic  resolution  structures  of 
PhyAmm in complex with IPs in several space groups. Structural differences associated 
with the various space groups have been analyzed and shown to be associated with the 
interface between the repeats of the individual monomer. As the active site is distant from 
this  interface,  it  is  not  surprising  the  active  site  difference  in  these  structures  are 
comparatively minor. The detailed interactions between PhyAmm and several IPs have 
also  been  characterized  and  compared  to  my  revised  model  of  PTPLP  substrate 
specificity derived from the known PhyAsr C252S:IP complex structures. 
4.1.1 Comparison of the PhyAmm structure in three space groups
X-ray crystallographic structures of PhyAmm C250S/C548S in complex with IPs 
were determined in P1 and C2 space groups at resolutions between 1.80 and 2.10 Å. The 
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crystal  growth conditions  for  these  complex structures  differ  from the  published apo 
structure by  Gruninger et al. (2009) and produced different space groups with different 
lattice contacts. In particular, the complex structures produced in this work include 20 % 
v/v glycerol which increases the efficiency of crystallizing PhyAmm. The published apo 
structure  has  a  space  group  of  P21 while  my  crystals  were  C2  and  P1  for  the  co-
crystalized and soaked crystals, respectively.
Complex crystals were originally produced by soaking substrate into preformed 
crystals grown in 20 % v/v glycerol, as the active sites in the apo PhyAmm crystals are 
accessible  to  the  solvent  channel  and  are  not  directly  involved  in  lattice  contacts 
(Gruninger et al., 2009). Subsequent to determining that the soaked complex crystal had a 
new  space  group  (P1),  crystals  were  generated  from  preformed  PhyAmm:ligand 
complexes (C2; co-crystallization). The generation of co-crystal and subsequent structure 
determination were conducted to  assess the possibility that significant conformational 
changes occur as a result of substrate binding.  
In  order  to  assess  the  structural  differences  within  the  PhyAmm  structures 
determined in the various space groups, I have used LSQ superpositions and an analysis 
of  intermolecular  contacts.  The  P21 (apo),  C2  (co-crystal),  and  P1  (soak)  structures 
contain  two  (molecules  A and  B),  one  (molecule  A)  and  four  (molecules  A to  D) 
monomers in the asymmetric unit, respectively. All molecules, in each space group  are 
present as dimers with buried surface areas calculated by PISA to be 4036, 3991, and 
4009  Å2,  respectively  (CCP4.,  1994).  Size  exclusion  chromatography  indicates  that 
PhyAmm behaves as a dimer in vitro, suggesting that the crystallographic dimer is also 
formed in solution (Gruninger et al., 2009). Similar to the P21 (apo) structure, the dimer 
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interface  of  each  structure  consists  of  an  extensive  network  of  hydrogen  bonds,  salt 
bridges and van der Waals contacts that form nearly identical dimer interfaces in all space 
groups (Gruninger et al., 2009). While the dimer interfaces in each of the structures are 
highly similar, LSQ superpositions of the protein backbones of the PhyAmm dimers have 
RMSDs between 0.56 and 0.60 Å (Table 4.1). These RMSDs are larger than expected for 
identical structures of this size, which are often less than 0.2 Å, the absolute coordinate 
error for structures at these resolutions. In order to identify the source of these larger than 
expected RMSDs, I superposed the monomers (Table 4.2) and tandem repeats (Table 4.3) 
of all molecules. The monomers of PhyAmm have RMSDs of 0.42 to 0.65 Å, suggesting 
that the structural differences in the dimers are present within the monomers. 
Table 4.1:  Pairwise RMSD comparison of PhyAmm dimers from P21 (apo), C2 (co-
crystal) and P1 (soak) space groups apo and in complex with IPs. RMSDs of the 1180 
Cαs of the dimers (Å) are shown. Chains A and B were used from the P1 structure.
Apo (3F41: P21) InsP6 + Pi (C2)
InsP6 + Pi (P1) 0.58 0.56
InsP6 + Pi (C2) 0.60
Table 4.2:  Pairwise RMSD comparison of PhyAmm from the P21, C2 and P1 space 
groups  apo and in  complex  with  IPs.  RMSDs of  the  monomers  (m),  N-  (n)  and C-
terminal (c) repeats (Å) are shown. LSQ main-chain superposition of the monomers, N- 
and C-terminal repeats with amino acids 47 to 636 (2360) 47 to 342 (1184 atoms) and 
343 to 636 (1176 atoms), respectively.
Apo (3F41: P21): A Apo (3F41: P21): B
m n c m n c
InsP6 + Pi (P1): A 0.52 0.37 0.35 0.64 0.37 0.40
InsP6 + Pi (P1): B 0.42 0.29 0.36 0.61 0.32 0.36
InsP6 + Pi (P1): C 0.58 0.32 0.41 0.43 0.34 0.37
InsP6 + Pi (P1): D 0.49 0.36 0.34 0.65 0.37 0.40
InsP6 + Pi (C2): A 0.52 0.39 0.47 0.64 0.37 0.45
Apo (3F41: P21): B 0.64 0.28 0.38
41
Table 4.3:  Pairwise RMSD internal  comparison of the PhyAmm N- and C-terminal 
repeats from the P21 and P1 space groups. RMSDs of the monomers (m), N- (n) and C-
terminal (c) repeats (Å) are shown. LSQ main-chain superposition of the monomers, N- 
and C-terminal repeats with amino acids 47 to 636 (2360) 47 to 342 (1184 atoms) and 
343 to 636 (1176 atoms), respectively.
InsP6 + Pi (P1): B InsP6 + Pi (P1): C InsP6 + Pi (P1): D
m n c m n c m n c
InsP6 + Pi (P1): A 0.34 0.21 0.35 0.45 0.23 0.39 0.14 0.11 0.14
InsP6 + Pi (P1): B 0.37 0.15 0.28 0.31 0.21 0.34
InsP6 + Pi (P1): C 0.46 0.23 0.40
Apo (3F41: P21): B
m n c
Apo (3F41: P21): A 0.64 0.23 0.38
The  RMSDs  of  the  individual  repeats  are  significantly  smaller  than  for  the 
monomers.  Superpositions  of  main-chain  N-terminal  repeats  have  RMSDs  that  are 
generally lower (0.15 to 0.23 Å) than the C-terminal repeat RMSDs which can be as high 
as 0.40 Å (Table 4.3). This is consistent with a conserved interaction between N-terminal 
repeats  at  the  dimer  interface  and a  more  flexible  linker  region between the  tandem 
repeats (Figure 4.1). The more flexible linker region allows the C-terminal repeats to 
adopt subtly different conformations that break the crystallographic symmetry observed 
in the P21 (apo) structure. Finally, I note that the two dimers in the P1 space group (AB, 
CD)  are  closely  related.  In  particular,  the  A and  D  monomers  (and  the  B  and  C 
monomers) have pairwise RMSDs comparable to those of the individual tandem repeats. 
Overall,  the  PhyAmm structures  found in  the  three  space  groups  have  nearly 
identical  structures  at  the  level  of  tandem  repeats  as  indicated  by  structural 
superpositions. As previously reported, the dimer interface is almost exclusively formed 
between N-terminal repeats and these interactions are preserved in each of the reported 
structures. Consequently, a somewhat flexible linker region between repeats allows small
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 Figure 4.1:  Ribbon diagram of a representative PhyAmm dimer. Dimer of molecules A 
(blue) and B (green) of the P1 PhyAmm C250S/C548S:InsP6 and inorganic phosphate 
structure. The N-terminal repeats (dark blue/green) are the source of the majority of the 
dimer interactions and the C-terminal repeat (light blue/green) contributes little to the 
dimer interaction resulting in a larger solvent-exposed surface. Ligands not shown.
movements of the tandem repeats relative to one another and accounts for the bulk of the 
observed differences between individual monomers and dimers in these structures.  Small 
differences at sites where lattice contacts are formed are also observed and do not directly 
involve the active sites of these enzymes. 
4.1.2 PhyAmm C250S/C548S Active Site
Having  characterized  the  differences  in  the  overall  structure  of  the  PhyAmm 
dimers,  monomers  and  tandem  repeats,  I  have  extended  the  analysis  to  active  site 
residues. Analysis of the 2Fo-Fc omit and Fo-Fc difference density maps clearly identified 
only inorganic phosphate bound in all active sites of the N-terminal repeats as was found 
by Gruninger et al. (2009). In contrast, the C-terminal repeats of each monomer contain 
clear  electron  density  corresponding  to  InsP6 and  Ins(1,3,4,5)P4.  In  each  case,  the 
identified ligands refined to occupancies between 75 and 100 %.
The RMSDs for the active-site main-chain atoms of the C-terminal repeats in my 
PhyAmm C250S/C548S:InsP6 complex  structures  (P1  and  C2)  are  less  than  0.20  Å 
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(Table 4.4). The RMSDs for the associated  side-chain atoms are less than 0.43  Å with 
significantly lower RMSDs within the P1 space group. The two outliers (RMSDs > 0.4 
Å) are caused by D484, M561, D563 and M565 which are not making contacts with the 
ligands  or  active-site  residues.  The  low RMSDs  for  the  highly  conserved  active-site 
residues is consistent with a largely preformed active site and a 'lock-and-key' binding 
mechanism  (Gruninger  et  al.,  2009).  Overall,  we  see  almost  identical  active  site 
conformations in the presence of substrate in all five N-terminal repeat:InsP6 complex 
structures (Figure 4.2).
Table  4.4:  Pairwise  RMSD  comparison  of  the  C-terminal  repeat  of  PhyAmm 
C250S/C548S in complex with InsP6 and inorganic phosphate. Main- (mc) and side-chain 
(sc) RMSDs (Å) of the active-site residues are shown. LSQ superposition of 184 and 216 
atoms was performed for the main- and side-chain atoms, respectively.
InsP6 + Pi (P1): B InsP6 + Pi (P1): C InsP6 + Pi (P1): D InsP6 + Pi (C2): A
mc sc mc sc mc sc mc sc
InsP6 + Pi (P1): A 0.12 0.16 0.20 0.14 0.09 0.15 0.18 0.42
InsP6 + Pi (P1): B 0.13 0.18 0.11 0.17 0.17 0.43
InsP6 + Pi (P1): C 0.13 0.20 0.14 0.20
InsP6 + Pi (P1): D 0.09 0.15
Having shown that InsP6 binding in the co-crystal and soaking experiments are 
virtually identical, I soaked PhyAmm C250S/C548S with Ins(1,3,4,5)P4 to produce the 
complex structure in the P1 space group. LSQ superpositions of the two P1 complex 
structures (InsP6 and Ins(1,3,4,5)P4) show that the paired A, B, C and D molecules are 
related by the monomer main-chain RMSDs (2360 atoms) of 0.22, 0.22, 0.25, and 0.23 
Å, respectively. Further, the LSQ superposition of the asymmetric unit contents (all 4 
molecules) from the InsP6 and Ins(1,3,4,5)P4, P1 complex structure shows a Cα (2360 
atoms) RMSD of 0.39 Å. To further characterize these structures, I performed pairwise 
LSQ superposition of  the  monomers  and N- and C-terminal  repeats  of  the  PhyAmm
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C250S/C548S Ins(1,3,4,5)P4 complex (Table 4.5). As with the InsP6 complex structure, 
we see the N-terminal repeat's RMSDs are lower than the C-terminal repeats' and both 
are lower than the monomer RMSDs. Additionally, the A and D monomers of the A-B 
and  C-D dimers  are  more  closely  related  to  one  another  than  to  either  the  B  or  C 
monomers. Likewise, B and C monomers of the two dimers are more closely related to 
one another than either the A or D monomers.  This suggests that the two dimers are 
equivalent even though the individual monomer adopts slightly different conformations. 
Figure  4.2:  Superposition  of  the  five  C-terminal  repeat  active-sites  from PhyAmm 
C250S/C548S  P1  and  C2  structures  (ribbons)  in  complex  with  InsP6 and  inorganic 
phosphate (sticks). The inorganic phosphate is bound to the P-loop with the InsP6 P5 
directly above. This figure demonstrates that each of the complex structures are nearly 
identical in the active site. Ligand atoms: phosphates are orange, oxygens are red, and 
carbons are grey. Protein  structures:  α-helices are red,  β-sheets are blue and loops are 
grey.
Table  4.5:  Pairwise  RMSD  internal  comparison  of  PhyAmm  C250S/C548S: 
Ins(1,3,4,5)P4 complex structure. RMSDs of the monomers (m), N- (n) and C-terminal (c) 
repeats  (Å)  are  shown.  LSQ  main-chain  superposition  of  the  monomers,  N-  and  C-
terminal repeats with amino acids 47 to 636 (2360) 47 to 342 (1184 atoms) and 343 to 
636 (1176 atoms), respectively.
Ins(1,3,4,5)P4: B Ins(1,3,4,5)P4: C Ins(1,3,4,5)P4: D
m n c m n c m n c
Ins(1,3,4,5)P4: A 0.36 0.18 0.38 0.63 0.24 0.42 0.14 0.11 0.14
Ins(1,3,4,5)P4: B 0.46 0.19 0.30 0.36 0.20 0.38
Ins(1,3,4,5)P4: C 0.65 0.25 0.43
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4.1.3 Myo-inositol phosphate binding to PhyAmm
Having demonstrated that all five active sites are nearly identical in the PhyAmm 
C250S/C548S InsP6 structures (both the P1 and C2), I will present the analysis of one 
interaction as they are qualitatively identical. I have chosen to utilize the P1 structure in 
the  following  analysis  because  it  was  solved  at  the  highest  resolution,  displays  the 
greatest  crystal  order  as  judged  by  Wilson  B-factors,  and  statistically  it  is  a  better 
structure (Table 2.4). In particular, the InsP6 ligand in molecule B of the P1 structure is 
used as it has the lowest average B-factors and most defined electron density. Unlike the 
PhyAmm C250S/C548S InsP6 complex structure, Ins(1,3,4,5)P4 binding to the C-terminal 
repeats of the P1 dimer differs. We see clear electron density for Ins(1,3,4,5)P4 bound to 
molecules A and D that refine at full occupancy while the electron density in the B and C 
active sites is sparse and a ligand other than inorganic phosphate cannot be modeled with 
confidence. The reasons for this difference are not readily apparent and suggest the small 
differences in the conformation and environment of the molecule B and C active sites 
affect Ins(1,3,4,5)P4, but not InsP6 binding. In the following analysis of protein:ligand 
interactions, I will utilize the Ins(1,3,4,5)P4 ligand of molecule A.
In all PhyAmm structures, inorganic phosphate is bound to the N-terminal repeats 
and only makes contacts with the P-loop and GA-loop of the PTP domain (Figure 4.3, 
Table 4.6). The contacts between the inorganic phosphate and the enzyme are identical to 
those observed in the N-terminal repeat (explained below) and in PhyAsr and PhyAmm 
structures lacking IP ligands.
46
   (a)           (b)
    
   (c)            (d)
    
Figure 4.3:  PhyAmm C250S/C548S in complex with IP substrates fit to the electron 
density  (Sigma-A weighted  2Fo-Fc)  associated  with  the  active  site,  contoured  at  1σ. 
Electron density of the PhyAmm C250S/C548S P1 structure of molecule B with (a) Pi, 
and  (b) InsP6 and Pi bound to the N- and C-terminal active sites, respectively. Electron 
density of the PhyAmm C250S/C548S crystals with eukaryotic IP Ins(1,3,4,5)P4 with (c) 
Pi and (d) Ins(1,3,4,5)P4 bound to the N- and C-terminal active sites, respectively, with P1 
of Ins(1,3,4,5)P4 bound to the P-loop. Phosphoryl binding sites labelled as in Figure 1.6, 
and highlight specific interactions between PhyAmm C250S/C548S and these substrates. 
Ligands and protein are shown as sticks with oxygens shown in red, nitrogens in blue, 
phosphorus in orange, sulfur in yellow, and carbons are grey.
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Table 4.6:  PhyAmm C250S/C548S contacts with inorganic phosphate in the N-terminal 
active sites of the P1 and C2 space groups. Contact distances (< 3.4 Å) between PhyAmm 
and inorganic phosphate are shown. Bolded distances are main-chain interactions.
InsP6 + Pi (B) Ins(1,3,4,5)P4 (A)
D221 Pi 3.40
S250 Pi 2.30 Pi 2.61
Y251 Pi Pi 3.17
A252 Pi
3.30
3.38 Pi 3.13
G253 Pi 2.95 Pi 3.08
M254 Pi 2.87 Pi 2.64
G255 Pi 3.14 Pi 2.283.23
R256 Pi
2.93
2.96
2.83
Pi
2.87
2.73
2.91
The PhyAmm C250S/C548S C-terminal repeat makes multiple contacts with both 
InsP6 and inorganic phosphate. As seen in Figure 4.2, the inorganic phosphate is bound 
within the Ps site while the InsP6 is bound above the inorganic phosphate. The observed 
complex  does  not  correspond  to  a  conformation  that  leads  to  InsP6 hydrolysis.  The 
presence of bound phosphate in each of the repeats is surprising as phosphate was not 
included in any of the crystallization media. Attempts to repeat the crystallization and 
soaking experiments using exhaustively dialyzed protein samples and InsP6 ligands of the 
highest purity available generate identical structures despite HPLC-based methods failing 
to detect phosphate in these samples at µM concentrations. I also tested soaked crystals 
for,  and  failed  to  detect,  the  presence  of  hydrolysis  products  using  modified  PAGE 
techniques. Finally, I determined the structure of co-crystals grown in the presence of 
InsP6 in  an  effort  to  obtain  an  InsP6 complex  structure  in  the  absence  of  inorganic 
phosphate and again, I obtained an identical structure (in a different space group; C2). At
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present,  I  am  forced  to  conclude  PhyAmm  tightly  binds  trace  levels  of  inorganic 
phosphate.
While the InsP6 ligand in the complex structures does not bind in a manner that 
leads to hydrolysis, it is similar to a previously described InsP5 product complex believed 
to  mimic  the  phosphoenzyme intermediate  in  PhyAsr  (Gruninger  et  al.,  2012).  InsP6 
makes  extensive  contacts  with  conserved,  previously  identified  active  site  residues 
(Figures 4.4, Table 4.7) that make use of the Pa, Pa', Pb and Pb' phosphoryl binding sites 
original  described  in  the  PhyAsr  C252S:InsP6 complex  and  the  PhyAsr  C252S:InsP5 
product complex (Gruninger et al., 2012).
The binding of Ins(1,3,4,5)P4 to the PhyAmm C-terminal repeat places the P1 
phosphate within the Ps site and the P3 through P5 phosphoryl groups in the Pa', Pc and Pb 
binding sites, respectively. This is consistent with the revised PTPLP substrate specificity 
model. Contacts  between  Ins(1,3,4,5)P4 and  the  enzyme  involve  the  same  set  of 
conserved  active  site  residues  observed  in  the  InsP6 complex  structure  (Table  4.7). 
Differences involve residues R362,  D449,  D519 and N585. In the case of R362 and 
N585, contacts are made to phosphoryl groups that are present in InsP6 but not present in 
the less phosphorylated Ins(1,3,4,5)P4. D519, the invariant general acid, adopts the same 
conformation  in  both  complex  structures.  The  D519  interaction  with  the  phosphoryl 
group in the Ps site in the Ins(1,3,4,5)P4 complex structure is slightly longer than the 3.4 
Å cutoff used in Table 4.7 due to differences in the positioning of the phosphoryl oxygen. 
The  additional  contact  involving  D449  in  the  Ins(1,3,4,5)P4 complex  structure  is  a 
consequence of the ligand binding deeper within the active site.
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Table 4.7:  PhyAmm C250S/C548S contacts with InsP6 and inorganic phosphate and the 
eukaryotic IP  Ins(1,3,4,5)P4 in the C-terminal active site.  Contact distances (< 3.4  Å) 
between PhyA and the ligand phosphoryl and hydroxyl groups are shown. Phosphoryl 
binding  sites  are  labelled  according  to  Figure  1.6. Bolded  distances  are  main-chain 
interactions.
InsP6 + Pi (B) Ins(1,3,4,5)P4 (A)
R351 Pa' P3 3.31 P3
3.31
2.71
2.72
R362 Pb' P3 2.92
D449 Pa' P3 2.95
K485 Pa'/Pc P4
3.00
3.40 P4
2.87
3.1
D519 Pa' P5 3.40
H520 Pa P5 2.72
P3
P5
2.81
3.11
S548 Ps Pi 2.27 P1 2.09
Q549 Ps
P4
Pi
3.01
3.16
P1
O2
2.94
3.34
A550 Ps Pi
3.11
3.28 P1 3.25
G551 Ps Pi 2.99 P1 3.10
A552 Ps Pi 2.95 P1 2.86
G553 Pa Pi 3.26
P1
O6
3.39
3.05
R554 Ps Pi
2.71
2.77
2.90
P1
2.67
3.01
2.78
N585 P6 2.82
K600 Pb/Pc
P5
P4
3.05
3.02
3.23
P5
P4
3.20
2.47
3.19
3.05
2.85
Y604 Pb P6
2.90
3.17 P5
2.46
2.87
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Figure 4.4:  Stick diagrams of PhyAmm C250S/C548S N-terminal active site in complex 
with  (a-b) InsP6 and inorganic phosphate and the  (c-d) eukaryotic Ins(1,3,4,5)P4.  (a-b) 
Inorganic phosphate is bound in Ps with P5 of InsP6 bound directly above. (c-d) The 
eukaryotic IP Ins(1,3,4,5)P4 with P1 bound to Ps. Residues that interact with the IPs are 
derived from the P-loop (yellow), GA-loop (cyan), Phy domain and penultimate helix 
(green).  (b  and d) Two-dimentional representation of the contacts made by PhyAmm 
C250S/C548S to each of the phosphoryl groups.  Oxygens shown in red, nitrogens in 
blue, phosphorus in orange, and carbons are grey or black. 
4.1.4 Comparison of ligand binding to PhyAmm C250S/C548S C-terminal repeat 
and PhyAsr C252S
A comparison between PhyAmm and PhyAsr's  active  sites  was  performed by 
Gruninger et al. (2009). The C-terminal repeat of PhyAmm has 48 % sequence identity 
with PhyAsr and LSQ superposition of the main-chain atoms results in a RMSD of 1.36 
Å over 272 residues (Gruninger et al., 2009). PhyAmm's C-terminal active site's volume 
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and depth are 7333 Å3 and 17 Å, respectively, while PhyAsr's active site is smaller with a 
volume of 5370 Å3 and depth of 14 Å, calculated by PISA  (Gruninger et  al.,  2009). 
Despite  the  size  differences,  the  active  sites  have  structurally  equivalent  residues 
contacting the Ins(1,3,4,5)P4 (Table 4.8). Additionally, the relative lengths of the contacts 
are comparable in both structures. Pairwise LSQ superposition of PhyAsr and PhyAmm's 
main-  (164  atoms)  and  side-chain  (178  atoms)  active-site  residues  contacting 
Ins(1,3,4,5)P4 results in RMSDs of 0.41 and 0.75 Å, respectively. Superposition of the P-
loop and flanking residues show that the complex structures are very similar with P1 of 
the Ins(1,3,4,5)P4 bound to the P-loop in the Ps site and P3, P4, and P5 are bound furthest 
from the P-loop in the Pa', Pc, and Pb, respectively (Figure 4.5). Further analysis of all 
residues contacting ligands in PhyAmm reveals R362 and N585 are involved in binding 
InsP6 while the equivalent residues in PhyAsr, R68 and F289 do not make direct contact. 
I also note K312 contacts InsP6 in the PhyAsr C252S (3MMJ) structure and while the 
equivalent PhyAmm residue (K607) does not. With the exception of N585, PhyAmm and 
PhyAsr  have  structurally  equivalent  residues  contacting  the  ligand  in  all  complex 
structures solved to date.
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Table 4.8:   PhyAmm C250S/C548S C-terminal active site and PhyAsr C252S contacts 
with the eukaryotic IP Ins(1,3,4,5)P4. Contact distances (< 3.4 Å) between PhyA and the 
ligand phosphoryl and hydroxyl groups are shown. Structurally equivalent residues are 
shown.  Phosphoryl binding sites are labelled according to Figure 1.6. Bolded distances 
are main-chain interactions.
PhyAmm PhyAsr
R351 Pa' P3
3.31
2.71
2.72
R57 Pa' P3
3.13
3.23
2.79
D449 Pa' P3 2.95 D153 Pa'
K485 Pa'/Pc P4
2.87
3.10 K189 Pa'/Pc 
P3
P4
2.62
3.02
D519 Pa' D223 Pa' P3
3.10
2.89
H520 Pa
P3
P5
2.81
3.11 H224 Pa
P3
P5
3.01
2.69
S548 Ps P1 2.09 S252 Ps P1 2.49
Q549 Ps
P1
O2
2.94
3.34 E253 Ps P1 3.01
A550 Ps P1 3.25 A254 Ps P1 3.17
G551 Ps P1 3.10 G255 Ps P1 2.93
A552 Ps P1 2.86 V256 Ps P1 2.61
G553 Pa
P1
O6
3.39
3.05 G257 Pa O6 3.07
R554 Ps P1
2.67
3.01
2.78
R258 Ps P1
2.92
3.06
2.98
K600 Pb/Pc
P5
P4
3.20
2.47
3.19
3.05
2.85
K305 Pb/Pc
P5
P4
2.33
3.19
2.35
2.32
Y604 Pb P5
2.46
2.87 Y309 Pb P5
2.27
3.12
53
Figure 4.5:  Binding of the eukaryotic IP Ins(1,3,4,5)P4 to PhyAmm C250S/C548S and 
PhyAsr C252S. Both structures have P1 bound to Ps. Residues that interact with the IPs 
are  derived from the  P-loop,  GA-loop,  Phy domain  and penultimate  helix  which  are 
shown as sticks. Oxygens are shown in red, nitrogens in blue, and phosphorus in orange. 
PhyAmm C250S/C548S C-terminal structure carbons are yellow and PhyAsr C252S are 
green.  Ins(1,3,4,5)P4 binds  nearly  identically  to  the PhyAsr and PhyAmm C-terminal 
active site.
4.2 Discussion
I  have  determined  the  structure  of  PhyAmm  C250S/C548S  in  complex  with 
several IPs. As part of this work, I have shown the PhyAmm C250S/C548S C-terminal 
active site remains static across three different space groups in the presence and absence 
of substrate. I have also shown that PhyAmm uses equivalent phosphoryl binding sites 
and binds Ins(1,3,4,5)P4 almost identically to PhyAsr. The PhyAmm C250S/C548S:InsP6 
complex structure suggests PhyAmm can bind substrates at other locations in the active 
site as observed in PhyAsr. Finally, I have analyzed the N-terminal repeat's ability to bind 
InsP6 and Ins(1,3,4,5)P4.
4.2.1 Comparison to the specificity models of PhyAsr
The similarities and differences between the structure of the PhyAmm C-terminal 
repeat and PhyAsr have been discussed previously (Gruninger et al., 2009). Here I have 
solved the first PhyAmm complex structures and have shown that the C-terminal repeat 
active site binds substrate in an equivalent manner using conserved active site residues 
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and phosphoryl binding sites. Consequently, these studies agree with current models of 
PTPLP substrate  specificity  (Chapter  1:  Section  1.2.4.1;  Chapter  3:  Discussion)  that 
account for many features of the known catalytic mechanism and hydrolysis pathway of 
PhyAsr  and  PhyAmm.  For  example,  the  PhyAmm  C250S/C548S  with  InsP6 and 
inorganic phosphate  complex structure  indicates  PhyAmm can bind substrate  in  non-
catalytically competent location using the same phosphoryl binding sites. This is similar 
to and supports previous work indicating that binding in PhyAsr may be a multi-step 
event that precedes hydrolysis (Gruninger et al., 2012). 
As both enzymes have very similar active sites and bind the Ins(1,3,4,5)P4 ligand 
nearly  identically,  the  PhyAsr  C252S:InsP6 complex structure  was  superposed on the 
PhyAmm C-terminal active site (Figure 4.6) to assess the ability of PhyAmm to bind 
InsP6 in the same manner as PhyAsr. The active sites superposed with RMSDs of 0.42 
and 0.82 Å for the main- (160 atoms) and side-chain (174 atoms) residues, respectively, 
which is comparable to the superposition of the two Ins(1,3,4,5)P4 structures. The InsP6 
modelled  in  the  PhyAmm  active  site  makes  contacts  with  each  of  the  identified 
phosphoryl  binding  sites  without  conformational  adjustments  and  does  not  result  in 
unfavourable  steric  contacts  (Figure  4.6).  This  suggests PhyAmm  can  bind  InsP6 
identically to PhyAsr, consistent with the known specificity of both enzymes for P3.
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Figure 4.6:  Superposition of PhyAmm C250S/C548S C-terminal active site and PhyAsr 
C252S bound to InsP6 (3MMJ). Residues that interact with the IP ligands are derived 
from the P-loop, GA-loop, Phy domain and penultimate helix which are shown as sticks. 
Oxygens are shown in red, nitrogens in blue, phosphorus in orange, and the IP carbons in 
grey.  PhyAmm  C250S/C548S  C-terminal  carbons  are  shown  in  yellow  and  PhyAsr 
C252S in green.  This figure suggests that InsP6 can bind to the PhyAmm C-terminal 
active site with P3 in the Ps site.
4.2.2 PhyAmm N-terminal active site
The PhyAmm N-terminal repeat shares 34 and 48 % sequence identity with the C-
terminal repeat and PhyAsr, respectively. The active site residues of the N-terminal repeat 
diverge  from  those  of  C-terminal  repeat  and  PhyAsr  (Figure  4.7).  Seven  active-site 
residues of 17 diverge when comparing the N-terminal repeat to the C-terminal repeat 
and PhyAsr. PhyAsr and PhyAmm C-terminal repeat only have three divergent residues, 
which are part of the P-loop and only make main-chain interactions with the IPs (Table 
4.8).  One  result  of  the  sequence  divergence  is  substitutions  of  non-polar  active-site 
residues  for  positively  charged  residues  decreasing  the  positive  electrostatic  surface 
potential of the N-terminal active site (Gruninger et al., 2009). A  major difference in the 
N-terminal active-site is a two residue insertion that results in a loop that overlaps the site 
where the K485 residue is located in the C-terminal repeat corresponding to the Pb' site. 
This loop causes steric clashes with the InsP6 when the PhyAsr C252S:InsP6 complex 
structure is superposed on the N-terminal active site (Figure 4.8a).  However, when the 
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PhyAmm Ins(1,3,4,5)P4 structure  is  superposed  on  the  N-terminal  repeat  these  steric 
clashes are not present (Figure 4.8b). This is consistent with the N-terminal repeat having 
activity toward less-phosphorylated IPs but not towards InsP6. While no Ins(1,3,4,5)P4 
binding to the N-terminal repeat is observed in this work, it is not a natural substrate for 
this enzyme. Alternate explanations for the lack of binding are considered in Chapter 5.
Figure 4.7: Alignment of the structurally equivalent active-site residues of the PhyAmm 
N- and C-terminal repeats and PhyAsr. The P-loop and GA-loops are highlighted in light 
grey.  
    (a)            (b)
    
Figure 4.8:  Superposition of InsP6 and Ins(1,3,4,5)P4 into PhyAmm C250S/C548S N-
terminal active site.  (a) InsP6 from the PhyAsr C252S (3MMJ) and  (b)  Ins(1,3,4,5)P4 
from  the PhyAmm  C250S/C548S  C-terminal  structures  superposed  on  PhyAmm 
C250S/C548S  N-terminal  active  site.  Oxygens  are  shown  in  red,  nitrogens  in  blue, 
phosphorus in orange, and the IP carbons in grey. This figure suggests that the PhyAmm 
N-terminal active site can bind an InsP4 but not InsP6 due to steric clashes.
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PhyAmm (N) K59 R70 D149 loop-insert D221 H222
PhyAmm (C) R351 R362 D449 K485 D519 H520
PhyAsr R57 R68 D153 K189 D223 H224
PhyAmm (N) S250 Y251 A252 G253 M254 G255 R256 V288
PhyAmm (C) S548 Q549 A550 G551 A552 G553 R554 N585
PhyAsr S252 E253 A254 G255 V256 G257 R258 F289
PhyAmm (N) G301 Y305 R308
PhyAmm (C) K600 Y604 K607
PhyAsr K305 Y309 K312
Chapter 5: Conclusions and Future Directions
5.1 Overview
In order to understand the substrate specificity of PTPLPs towards IPs, I have 
determined the first structures of several PTPLPs in complex with less-phosphorylated 
substrates. In this thesis, I describe the atomic resolution structures of the PTPLPs from 
S.  ruminantium (PhyAsr)  and  M. multacida (PhyAmm) in  complex with several  IPs. 
Based on these structural studies, I have identified differences in the binding of less-
phosphorylated substrates and identified specific interactions that allow me to revise the 
simple PTPLP substrate specificity model. As part of this work, I have produced the first 
PhyAmm complex structures, and shown that the PhyAmm C-terminal repeat and PhyAsr 
bind  substrates  using  identical  phosphoryl  binding  sites.  Additionally,  I  have 
demonstrated  that  these  enzymes  bind  substrates  consistent  with  a  'lock-and-key' 
mechanism and provide evidence that the difference in the PhyAmm N- and C-terminal 
substrate binding is likely due to electrostatic differences and a loop insertion causing 
steric clashes. 
In  Chapter  3,  I  present  four  separate  PhyAsr  complex  structures  with  less-
phosphorylated IPs and demonstrate the previously identified substrate binding sites are 
utilized by each structure. Notably, the IPs adopt alternate ring conformations from InsP6 
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resulting  in  additional  contacts  in  the  Pb and  Pc sites.  Further,  the  alternate  ring 
conformations allow phosphoryl groups that are not adjacent to the scissile phosphate to 
occupy the Pa' site, which is not predicted by the simple substrate specificity model. This 
has allowed me to revise the simple specificity model, which can now account for all 
major and minor pathway products generated by PhyAsr (and PhyAmm). Interestingly, 
there is a difference in prokaryotic (contain the axial P2) and eukaryotic (lack the axial 
P2) IP binding. I note that the eukaryotic IPs are tilted closer toward the GA-loop than the 
prokaryotic IPs. This difference can be explained by the presence of the axial P2 in the 
prokaryotic IPs. An axial P2 steric clash with the GA-loop prevents the prokaryotic IPs 
from binding as  deep into the active site  as the eukaryotic  IPs,  which lack the axial 
phosphoryl group. As demonstrated above, the ring tilt affects the binding of phosphoryl 
groups of less-phosphorylated substrates in the active site and likely contributes to the 
enzyme's ability to hydrolyze substrates in a specific order.
Finally, in Chapter 4 I solved the first PhyAmm IP complex structures. Similarly 
to  PhyAsr,  the PhyAmm C-terminal repeat  active site  is  preformed and is  essentially 
unchanged in the presence and absence of ligand. I have determined the structure of co-
crystallized  and  soaked  PhyAmm  C250S/C548S:InsP6 complexes  and  despite  the 
different space groups, the PhyAmm complex structures demonstrate that the C-terminal 
active  site  conformation  is  not  affected  by  lattice  contacts,  dimerization  or  substrate 
binding. Further, the PhyAmm C-terminal active site is almost identical to the PhyAsr 
active site and Ins(1,3,4,5)P4 binding is nearly identical. Overall, the complex structures 
indicate PhyAmm has identical phosphoryl binding sites to PhyAsr, which is consistent 
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with  the  revised  specificity  model  and even supports  previous  suggestions  that  these 
enzymes can bind substrates at multiple locations within the active site.
5.2 PTPLP substrate specificity model
The simple PTPLP specificity model based on the PhyAsr C252S:InsP6 complex 
structure rationalizes the observed major hydrolysis pathway of PhyAsr using a few basic 
rules. This model has several weaknesses that arise from a lack of structural data and the 
simplicity of its rules. While the model accounts for the binding and hydrolysis of 12 of 
the 13 observed IP substrates utilized by PhyAsr and PhyAmm, it fails in a single case. 
The sole exception is the conversion of Ins(1,2,4,5,6)P5 to Ins(1,2,4,6)P4 along one of the 
minor hydrolysis pathways. In this case, the equatorial  P4 or P6 phosphoryl group is 
located  adjacent  to  the  scissile  phosphate  (P5)  and,  according  to  the  simple  model, 
directed into the Pa' site. Additionally, there are several potential solutions for almost all 
IPs that contain four or fewer phosphoryl groups when the simple model is utilized.
In this work, I have shown that the less-phosphorylated InsP4 and InsP3 substrates 
bind with an altered ring position (i.e. tilted towards the GA-loop) within the preformed 
PhyAsr and PhyAmm active sites. The altered ring position provides additional access for 
phosphoryl groups to bind in the Pa' site, generating several unique interactions between 
the  enzyme  and  the  less-phosphorylated  IPs.  In  each  of  the  PhyAsr  and  PhyAmm 
complex structures, the movement in the ring position allows phosphoryl groups that are 
not adjacent to the scissile phosphate (i.e. by the simple model, directed into the Pb' site) 
to occupy the Pa' site. The movement allows the phosphoryl group to make up to four 
additional contacts with the Pa' site in comparison to the Pb' site. This potentially explains 
the binding and hydrolysis of Ins(1,2,4,5,6)P5 that is not accounted for by the simple 
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specificity  model (Figure 5.1). Without the observed ring movement (and rotation) by 
InsP4 and InsP3, any equatorial phosphoryl group adjacent to the scissile phosphate would 
result in steric clashes in the Pa' site. As this is the case for the Ins(1,2,4,5,6)P5 substrate, I 
have a reasonable explanation for the sole exception to the simple substrate specificity 
model.  Assuming  Ins(1,2,4,5,6)P5 substrate  binding  is  accompanied  by  a  similar  (or 
lesser)  ring  movements,  the  steric  clashes  with  the  Pa'  site  predicted  by  the  simple 
substrate specificity model would be greatly reduced and avoided if the adjacent Pb' site 
contains  a  hydroxyl  group.  Further,  the  revised  specificity  model  predicts  different 
substrate conformations for InsP3 and InsP2 than the simple model (Figure  5.2). In each 
of the cases in Figure 5.2, P2 is in the Pb or Pb' site. The simple model predicts P2 will 
bind  in  the  Pb site  based  on stronger  binding to  Pb than Pb'.  In  the  revised model,  a 
phosphoryl  group is  directed  into  the  Pb' site  and occupies  the  Pa' site,  which  is  the 
stronger interaction based on the number of direct contacts. Consequently, the revised 
model favours P2 binding in the Pb' site (opposite to the simple model), consistent with 
the structures in this work. In summary, the first rule of the revised substrate specificity 
model is that the Pa' site can accommodate an axial phosphoryl group (P2), a hydroxyl 
group, or phosphoryl groups not adjacent to the scissile phosphate in less-phosphorylated 
IPs, and the second rule is to preferentially fill the Pa and Pa' 'strong interacting' sites.
Figure 5.1:  Possible binding modes of Ins(1,2,4,5,6)P5 to produce the minor pathway 
Ins(1,2,4,6)P4.  The  left  panel  is  InsP5 binding  as  predicted  by  the  simple  substrate 
specificity  model,  the  right  panel  is  binding  as  predicted  by  the  revised  model.  The 
revised specificity model predicts that inositol ring movement and the hydroxyl in the Pb' 
site, would greatly reduced steric clashes.
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Figure 5.2:  Predictions of (a) Ins(1,2,4)P3 and (b) Ins(2,4)P2 binding according to the 
revised substrate specificity model. The left panels are IPs binding as predicted by the 
simple substrate specificity model, the right panel are IPs binding as predicted by the 
revised model. The binding mode of the IPs cannot be predicted by the simple substrate 
specificity model, whereas the revised substrate specificity model predicts the IPs bind 
according to the right panels of (a) and (b).
5.3 Non-canonical substrate binding
As  indicated  in  the  Chapter  3  and  Chapter  4  discussions,  the  PhyAsr 
C252S:Ins(1,2,5,6)P4,  PhyAmm  C250S/C548S:Ins(1,2,5,6)P4 and  PhyAsr 
C252S:Ins(2,4,5)P3 complex  structures  are  consistent  with  my  revised  substrate 
specificity model. However, in each of these complex structures the P4 phosphoryl group 
is bound in the Ps site, while the known hydrolysis pathway predicts P6 (InsP4) and P5 
(InsP3) as the scissile phosphoryl groups. In order to understand the differences between 
the observed and expected phosphoryl group in the Ps site we have investigated four 
possibilities: conformational changes upon substrate binding, small molecules from the IP 
purification  influencing  substrate  binding,  incorrect  dephosphorylation  pathways,  and 
crystallization conditions influencing substrate binding. 
First,  I  grew co-crystals  of  the  PhyAmm C250S/C548S:InsP6 complex  in  the 
event there are conformational changes in the active site that accompany the binding of 
substrates. As discussed in Chapter 4, I successfully produced a novel crystal form (C2 
space group) suggesting that a conformational change does occur with substrate binding. 
However, careful comparison of this structure to the apo PhyAmm structure (P21 space 
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group)  and to  the  soaked PhyAmm C250S/C548S:InsP6 complex structure  (P1 space 
group)  indicates  that  these  conformational  differences  are  due  to  subtle  movements 
between repeats and do not affect the active site. While I did not generate a co-crystal of 
PhyAsr, previous studies have indicated the active site conformation of PhyAsr remains 
constant between crystals grown in different conditions, from 1.35 M (NH4)SO4, to 8 % 
(v/v) PEG 8000 (Puhl et al., 2007; Gruninger et al., 2008). Additionally, the intentional 
oxidation of the nucleophilic C252 of PhyAsr only affects the conformation of the P-loop 
residues (Gruninger et al., 2008). While these studies and observations do not eliminate 
the possibility of conformational changes within the active site, the available structural 
data clearly indicates the active sites of PhyAmm and PhyAsr are essentially preformed. 
Therefore, significant conformational changes are unlikely to account for the difference 
between the observed and expected substrate binding in my complex structures.
I also considered the possibility that our methods for InsP4 and InsP3 production 
may have influenced the observed structures (Chapter 2: Section 2.1). While it is possible 
Ca2+ or some other small molecule is present in these samples, there is no evidence for 
such ions or molecules in my structures (other than those common to all crystallization 
media). Consequently, it is difficult to understand how an ion or small molecule derived 
from my purification could result in the observed binding differences.
Given  that  I  produced  and  purified  an  unexpected  minor  pathway  product 
(Ins(1,2,4,6)P4), by Ca2+ induced precipitation at alkaline pH, I considered the possibility 
that the published hydrolysis pathway is incorrect and repeated published HPLC methods 
used  to  identify  IP  products  based  upon  the  retention  times  of  known  standards 
(Blaabjerg et al., 2010). The results were consistent with published data and supported 
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the published hydrolysis pathway. Oddly, the InsP3 ligand produced and purified by the 
same Ca2+ precipitation method corresponds to a major pathway product. Therefore, it 
seems the Ca2+ induced precipitation selectively precipitates the InsP4 ligand of the minor 
pathway. 
Finally,  I  considered  the  possibility  that  my  crystallization  conditions  were 
influencing  substrate  binding.  Surprisingly,  we  have  recently  shown  that  glycerol, 
typically a benign additive that enhances protein solubility, is an inhibitor of PhyAmm 
and  PhyAsr  mediated  hydrolysis  in  simple  activity  assays  (unpublished).  At  glycerol 
concentrations equivalent to those present in my crystallization media (20 % v/v), both 
PhyAsr and PhyAmm have less than 50 % of their optimal activity. To my knowledge, 
this is the first report of a phosphatase that is inhibited by glycerol. While the mechanism 
of inhibition has not been determined I note that electron density for glycerol is observed 
in all my PhyAsr and PhyAmm structures. However, these glycerol ligands do not occupy 
the active sites of the enzymes suggesting they are not competitive inhibitors. Given the 
absence of structural changes in the active site of PhyAsr and PhyAmm, the inhibitory 
mechanism  does  not  appear  to  be  due  to  glycerol  binding.  This  would  suggest  the 
inhibition arises from changes in the bulk properties of the crystallization media and is 
consistent with PhyAmm pH vs. rate plots that are multimodal at low salt concentrations 
(personal communication).  To test this idea we, repeated simple kinetics assays using 
ethanol and 2-methyl-2,4-pentanediol in place of glycerol and obtained similar results 
indicating bulk properties of the crystallization media is the source of the inhibition.
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5.4 Future directions
The  work  presented  in  this  thesis  represents  the  first  structures  of  less-
phosphorylated prokaryotic IPs in complex with PhyAsr and the first structures of the 
related  PhyAmm  in  complex  with  IPs.  While  these  results  contribute  to  our 
understanding  of  the  structural  basis  of  PTPLP substrate  specificity,  our  knowledge 
remains incomplete. Some questions arise as a direct result of the work presented here. 
For example, how is glycerol affecting enzyme activity; does it affect substrate binding or 
even the hydrolysis pathway? In more practical terms, will we see canonical binding of 
substrates to PhyAsr and PhyAmm (both repeats) when co-crystalized or soaked in the 
absence of glycerol? Other obvious examples, include testing (e.g. kinetic and binding 
assays) site-directed mutations of the K305 and Pa' site residues that have unique roles in 
the binding of less-phosphorylated substrates. Likewise, atomic resolution structures of 
PhyAsr InsP5 and InsP2 complexes will complete our understanding of myo-inositol ring 
location in the active site and its relation to substrate binding. The methodologies for the 
structural studies referred to above are largely developed in this work. With the rapid 
development of our ability to produce large quantities of highly purified substrates, these 
studies are now more feasible than before.
Larger questions involving the development of rationally designed PTPLPs also 
remain unanswered. To date, the structures of representative enzymes in complex with 
selected IP substrates have identified a series of structural determinants that likely affect 
enzyme activity. For many structural determinants, their roles have been confirmed using 
site-directed mutagenesis and simple kinetics assays  (Chu et al., 2004; Puhl et al., 2007). 
While we have not yet analyzed the hydrolysis pathway of our initial mutants, we have 
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reactivated  PhyAmm  activity  towards  InsP6 by  introducing  as  few  as  two  residues 
(unpublished). Future atomic resolution structural and substrate specificity studies will 
focus  on  enzymes  with  divergent  active  site  sequences  in  order  to  understand  the 
structural differences and the basis for their specificity. Particularly interesting are the 
IPases with narrow IP specificity, as they are fundamentally different in comparison with 
PhyAsr and PhyAmm. Likewise, those enzymes that remove the C5-phosphoryl group 
from InsP6 are notable as they would allow us to produce a second series of IP substrates 
and allow us to further investigate the substrate specificity towards a broader range of IP 
substrates. 
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